Document:

WELLS FARGO & COMPANY 8-K

 

Exhibit 4.4

 

[Face
of Note]

 

Unless
this certificate is presented by an authorized representative of The Depository Trust Company, a New York corporation (“DTC”),
to the Company or its agent for registration of transfer, exchange or payment, and any certificate issued is registered in the
name of Cede & Co. or in such other name as requested by an authorized representative of DTC (and any payment is made to Cede & Co. or such other entity as is requested by an authorized representative of DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF
FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL inasmuch as the registered owner hereof, Cede & Co., has an interest
herein.

 

	CUSIP NO. 95001HA43

	FACE
AMOUNT:  $______________

	REGISTERED NO. __

	 

 

WELLS
FARGO FINANCE LLC

 

MEDIUM-TERM
NOTE, SERIES A 

Fully
and Unconditionally Guaranteed by Wells Fargo & Company

 

Principal
at Risk Securities Linked to the Dow Jones Industrial Average®
due September 11, 2023

 

WELLS
FARGO FINANCE LLC, a limited liability company duly organized and existing under the laws of the State of Delaware (hereinafter
called the “Company,” which term includes any successor corporation under and as defined in the Indenture hereinafter
referred to), for value received, hereby promises to pay to CEDE & Co., or registered assigns, an amount equal to the
Maturity Payment Amount (as defined below), in such coin or currency of the United States of America as at the time of payment
is legal tender for payment of public and private debts, on the Stated Maturity Date, unless this Security is automatically called
as provided below under “Automatic Call.”  The “Initial Stated Maturity Date” shall be September 11,
2023.  If the Final Calculation Day (as defined below) is not postponed, the Initial Stated Maturity Date will be the “Stated
Maturity Date.”  If the Final Calculation Day is postponed, the “Stated Maturity Date” shall
be the later of (i) the Initial Stated Maturity Date and (ii) three Business Days (as defined below) after the Final
Calculation Day as postponed.  This Security shall not bear any interest. 

 

Any
payments on this Security at Maturity will be made against presentation of this Security at the office or agency of the Company
maintained for that purpose in the City of Minneapolis, Minnesota and at any other office or agency maintained by the Company
for such purpose. 

 

“Face
Amount” shall mean, when used with respect to this Security, the amount set forth on the face of this Security as its
“Face Amount.”

 

     

     

    
Automatic
Call

 

If
the Closing Level (as defined below) of the Index (as defined below) on any of the Call Dates (as defined in the table below)
is greater than or equal to the Starting Level (as defined below), this Security will be automatically called, and on the related
Call Settlement Date (as defined below) the Holder hereof will receive the Face Amount of this Security plus the Call Premium
(as defined in the table below) applicable to the relevant Call Date (together, the “Call Price”).  Unless the
Company defaults in the payment of the Call Price, this Security will cease to be outstanding on such Call Settlement Date, and
the Holder hereof will have no further rights under this Security after such Call Settlement Date.  The Holder hereof will
not receive any notice from the Company in the event this Security is automatically called pursuant to the terms hereof.

 

The
Call Dates and the related Call Premiums are as follows:

 

	 

	Call Date

	Call Premium

	 	 	 
	 

	September 10, 2020

	  6.10% of the Face
Amount of this Security

	 

	September 9, 2021

	12.20% of the Face
Amount of this Security

	 

	September 9, 2022

	18.30% of the Face
Amount of this Security

	 

	September 1, 2023

	24.40% of the Face
Amount of this Security

 

The
Call Dates are subject to postponement for non-Trading Days and the occurrence of a Market Disruption Event.  See the definition
of “Calculation Days” below.

 

The
“Call Settlement Date” for a Call Date shall be five Business Days after such Call Date, as such Call Date
may be postponed as provided herein; provided that the Call Settlement Date for the last Call Date shall be the Stated Maturity
Date.

 

Payment
of the Call Price, if any, will be made in such coin or currency of the United States of America as at the time is legal tender
for payment of public and private debts.

 

Determination
of Maturity Payment Amount and Certain Definitions

 

If
this Security is not automatically called as provided above under “Automatic Call,” the “Maturity Payment
Amount” of this Security will equal:

 

	 

	●

	if
the Ending Level is less than the Starting Level but greater than or equal to the Threshold Level: the Face Amount; or

 

	 

	●

	if
the Ending Level is less than the Threshold Level: the Face Amount minus:

 

 

 

All
calculations with respect to the Maturity Payment Amount or Call
Price, as applicable, will be rounded to the nearest one hundred-thousandth, with five one-millionths rounded upward 

 

    2 

     

    
 

(e.g., 0.000005
would be rounded to 0.00001); and the Maturity Payment Amount
or Call Price, as applicable, will be rounded to the nearest cent, with one-half cent rounded upward.

 

“Index”
shall mean the Dow Jones Industrial Average®.

 

The
“Pricing Date” shall mean August 30, 2019.

 

The
“Starting Level” is 26403.28, the Closing Level of the Index on the Pricing Date.

 

The
“Closing Level” of the Index on any Trading Day means the official closing level of the Index reported by the
Index Sponsor (as defined below) on such Trading Day, as obtained by the Calculation Agent on such Trading Day from the licensed
third-party market data vendor contracted by the Calculation Agent at such time; in particular, taking into account the decimal
precision and/or rounding convention employed by such licensed third-party market data vendor on such date, subject to the provisions
set forth below under “Market Disruption Events,” “Adjustments to the Index” and “Discontinuance
of the Index.”

 

The
“Ending Level” will be the Closing Level of the Index on the Final Calculation Day.

 

The
“Threshold Level” is 23762.952, which is equal to 90% of the Starting Level.

 

“Business
Day” shall mean a day, other than a Saturday or Sunday, that is neither a legal holiday nor a day on which banking institutions
are authorized or required by law or regulation to close in New York, New York.

 

A
“Trading Day” means a day, as determined by the Calculation Agent, on which (i) the Relevant Stock Exchanges
with respect to each security underlying the Index are scheduled to be open for trading for their respective regular trading sessions
and (ii) each Related Futures or Options Exchange is scheduled to be open for trading for its regular trading session.

 

The
“Relevant Stock Exchange” for any security underlying the Index means the primary exchange or quotation system
on which such security is traded, as determined by the Calculation Agent.

 

The
“Related Futures or Options Exchange” for the Index means an exchange or quotation system where trading has
a material effect (as determined by the Calculation Agent) on the overall market for futures or options contracts relating to
the Index.

 

The
“Calculation Days” shall mean each of the Call Dates (including the Final Calculation Day).  If any Calculation
Day is not a Trading Day, such Calculation Day will be postponed to the next succeeding Trading Day.  A Calculation Day is
also subject to postponement due to the occurrence of a Market Disruption Event (as defined below). If a Market Disruption Event
occurs or is continuing with respect to the Index on a Calculation Day, such Calculation Day will be postponed to the first succeeding
Trading Day on which a Market Disruption Event has not occurred and is not continuing; however, if such first succeeding Trading
Day has not occurred as of the eighth Trading Day after the originally scheduled

 

    3 

     

    
 

Calculation Day, that eighth Trading Day shall
be deemed to be the Calculation Day.  If a Calculation Day has been postponed eight Trading Days after the originally scheduled
Calculation Day and a Market Disruption Event occurs or is continuing on such eighth Trading Day, the Calculation Agent will determine
the Closing Level of the Index on such eighth Trading Day in accordance with the formula for and method of calculating the Closing
Level of the Index last in effect prior to commencement of the Market Disruption Event, using the closing price (or, with respect
to any relevant security, if a Market Disruption Event has occurred with respect to such security, its good faith estimate of
the value of such security at the Scheduled Closing Time of the Relevant Stock Exchange for such security or, if earlier, the
actual closing time of the regular trading session of such Relevant Stock Exchange) on such date of each security included in
the Index.  As used herein, “closing price” means, with respect to any security on any date, the Relevant
Stock Exchange traded or quoted price of such security as of the Scheduled Closing Time of the Relevant Stock Exchange for such
security or, if earlier, the actual closing time of the regular trading session of such Relevant Stock Exchange.

 

The
“Final Calculation Day” is September 1, 2023, subject to postponement as provided herein.

 

“Calculation
Agent Agreement” shall mean the Calculation Agent Agreement dated as of May 18, 2018 between the Company and the
Calculation Agent, as amended from time to time.

 

“Calculation
Agent” shall mean the Person that has entered into the Calculation Agent Agreement with the Company providing for, among
other things, the determination of whether this Security will be automatically called on any of the Call Dates, the Call Price,
if any, the Ending Level and the Maturity Payment Amount, which
term shall, unless the context otherwise requires, include its successors under such Calculation Agent Agreement.  The initial
Calculation Agent shall be Wells Fargo Securities, LLC.  Pursuant to the Calculation Agent Agreement, the Company may appoint
a different Calculation Agent from time to time after the initial issuance of this Security without the consent of the Holder
of this Security and without notifying the Holder of this Security.

 

Adjustments
to the Index

 

If
at any time the method of calculating the Index or a Successor Equity Index, or the closing level thereof, is changed in a material
respect, or if the Index or a Successor Equity Index is in any other way modified so that such index does not, in the opinion
of the Calculation Agent, fairly represent the level of such index had those changes or modifications not been made, then the
Calculation Agent will, at the close of business in New York, New York,
on each date that the closing level of such index is to be calculated, make such calculations and adjustments as, in the
good faith judgment of the Calculation Agent, may be necessary in order to arrive at a level of an index comparable to the Index
or Successor Equity Index as if those changes or modifications had not been made, and the Calculation Agent will calculate the
closing level of the Index or Successor Equity Index with reference to such index, as so adjusted. Accordingly, if the method
of calculating the Index or Successor Equity Index is modified so that the level of such index is a fraction or a multiple of
what it would have been if it had not been modified (e.g., due to a split or reverse split in such equity index), then
the Calculation Agent will adjust the

 

    4 

     

    
 

Index or Successor Equity Index in order to arrive at a level of such index as if it had
not been modified (e.g., as if the split or reverse split had not occurred).

 

Discontinuance
of the Index

 

If
the sponsor or publisher of the Index (the “Index Sponsor”) discontinues publication of the Index, and the
Index Sponsor or another entity publishes a successor or substitute equity index that the Calculation Agent determines, in its
sole discretion, to be comparable to the Index (a “Successor Equity Index”), then, upon the Calculation Agent’s
notification of that determination to the Trustee and the Company, the Calculation Agent will substitute the Successor Equity
Index as calculated by the Index Sponsor or any other entity and calculate the Ending Level or the Closing Level on any Calculation
Day as described above. Upon any selection by the Calculation Agent of a Successor Equity Index, the Company will cause notice
to be given to the Holder of this Security.

 

In
the event that the Index Sponsor discontinues publication of the Index prior to, and the discontinuance is continuing on, a Calculation
Day and the Calculation Agent determines that no Successor Equity Index is available at such time, the Calculation Agent will
calculate a substitute Closing Level for the Index in accordance with the formula for and method of calculating the Index last
in effect prior to the discontinuance, but using only those securities that comprised the Index immediately prior to that discontinuance. 
If a Successor Equity Index is selected or the Calculation Agent calculates a level as a substitute for the Index, the Successor
Equity Index or level will be used as a substitute for the Index for all purposes, including the purpose of determining whether
a Market Disruption Event exists.

 

If
on a Calculation Day the Index Sponsor fails to calculate and announce the level of the Index, the Calculation Agent will calculate
a substitute Closing Level of the Index in accordance with the formula for and method of calculating the Index last in effect
prior to the failure, but using only those securities that comprised the Index immediately prior to that failure; provided
that, if a Market Disruption Event occurs or is continuing on such day, then the provisions set forth above under the definition
of “Calculation Day” shall apply in lieu of the foregoing.

 

Market
Disruption Events 

 

A
“Market Disruption Event” means any of the following events as determined by the Calculation Agent in its sole
discretion:

 

	 

	(A)

	The
occurrence or existence of a material suspension of or limitation imposed on trading by the Relevant Stock Exchanges or otherwise
relating to securities which then comprise 20% or more of the level of the Index or any Successor Equity Index at any time during
the one-hour period that ends at the Close of Trading on that day, whether by reason of movements in price exceeding limits permitted
by those Relevant Stock Exchanges or otherwise.

 

	 

	(B)

	The
occurrence or existence of a material suspension of or limitation imposed on trading by any Related Futures or Options Exchange
or otherwise in futures or 

    5 

     

    
 

	 

	 

	options contracts relating to the Index or any Successor Equity Index on any Related Futures or Options
Exchange at any time during the one-hour period that ends at the Close of Trading on that day, whether by reason of movements
in price exceeding limits permitted by the Related Futures or Options Exchange or otherwise. 

 

	 

	(C)

	The
occurrence or existence of any event, other than an early closure, that materially disrupts or impairs the ability of market participants
in general to effect transactions in, or obtain market values for, securities that then comprise 20% or more of the level of the
Index or any Successor Equity Index on their Relevant Stock Exchanges at any time during the one-hour period that ends at the
Close of Trading on that day.

 

	 

	(D)

	The
occurrence or existence of any event, other than an early closure, that materially disrupts or impairs the ability of market participants
in general to effect transactions in, or obtain market values for, futures or options contracts relating to the Index or any Successor
Equity Index on any Related Futures or Options Exchange at any time during the one-hour period that ends at the Close of Trading
on that day.

 

	 

	(E)

	The
closure on any Exchange Business Day of the Relevant Stock Exchanges on which securities that then comprise 20% or more of the
level of the Index or any Successor Equity Index are traded or any Related Futures or Options Exchange prior to its Scheduled
Closing Time unless the earlier closing time is announced by the Relevant Stock Exchange or Related Futures or Options Exchange,
as applicable, at least one hour prior to the earlier of (1) the actual closing time for the regular trading session on such
Relevant Stock Exchange or Related Futures or Options Exchange, as applicable, and (2) the submission deadline for orders
to be entered into the Relevant Stock Exchange or Related Futures or Options Exchange, as applicable, system for execution at
such actual closing time on that day.

 

	 

	(F)

	The
Relevant Stock Exchange for any security underlying the Index or Successor Equity Index or any Related Futures or Options Exchange
fails to open for trading during its regular trading session.

 

For
purposes of determining whether a Market Disruption Event has occurred:

 

	 

	(1)

	the
relevant percentage contribution of a security to the level of the Index or any Successor Equity Index will be based on a comparison
of (x) the portion of the level of such Index attributable to that security and (y) the overall level of the Index or
Successor Equity Index, in each case immediately before the occurrence of the Market Disruption Event;

 

	 

	(2)

	the
“Close of Trading” on any Trading Day for the Index or any Successor Equity Index means the Scheduled Closing
Time of the Relevant Stock Exchanges with respect to the securities underlying the Index or Successor Equity Index on such

 

    6 

     

    
	 

	 

	Trading
Day; provided that, if the actual closing time of the regular trading session of any such Relevant Stock Exchange is earlier
than its Scheduled Closing Time on such Trading Day, then (x) for purposes of clauses (A) and (C) of the definition of “Market
Disruption Event” above, with respect to any security underlying the Index or Successor Equity Index for which such Relevant
Stock Exchange is its Relevant Stock Exchange, the “Close of Trading” means such actual closing time and (y) for purposes
of clauses (B) and (D) of the definition of “Market Disruption Event” above, with respect to any futures or options
contract relating to the Index or Successor Equity Index, the “close of trading” means the latest actual closing time
of the regular trading session of any of the Relevant Stock Exchanges, but in no event later than the Scheduled Closing Time of
the Relevant Stock Exchanges;

 

	 

	(3)

	the
“Scheduled Closing Time” of any Relevant Stock Exchange or Related Futures or Options Exchange on any Trading
Day for the Index or any Successor Equity Index means the scheduled weekday closing time of such Relevant Stock Exchange or Related
Futures or Options Exchange on such Trading Day, without regard to after hours or any other trading outside the regular trading
session hours; and

 

	 

	(4)

	an
“Exchange Business Day” means any Trading Day for the Index or any Successor Equity Index on which each Relevant
Stock Exchange for the securities underlying the Index or any Successor Equity Index and each Related Futures or Options Exchange
are open for trading during their respective regular trading sessions, notwithstanding any such Relevant Stock Exchange or Related
Futures or Options Exchange closing prior to its Scheduled Closing Time.

 

Calculation
Agent

 

The
Calculation Agent will determine whether this Security will be automatically called on any of the Call Dates, the Call Price,
if any, the Maturity Payment Amount and the Ending Level.  In addition, the Calculation Agent will (i) determine if adjustments
are required to the Closing Level of the Index under the circumstances described in this Security, (ii) if publication of the
Index is discontinued, select a Successor Equity Index or, if no Successor Equity Index is available, determine the Closing Level
of the Index under the circumstances described in this Security, and (iii) determine whether a Market Disruption Event or non-Trading
Day has occurred. 

 

The
Company covenants that, so long as this Security is Outstanding, there shall at all times be a Calculation Agent (which shall
be a broker-dealer, bank or other financial institution) with respect to this Security.

 

All
determinations made by the Calculation Agent with respect to this Security will be at the sole discretion of the Calculation Agent
and, in the absence of manifest error, will be conclusive for all purposes and binding on the Company and the Holder of this Security.

 

    7 

     

    
Tax
Considerations

 

The
Company agrees, and by acceptance of a beneficial ownership interest in this Security each Holder of this Security will be deemed
to have agreed (in the absence of a statutory, regulatory, administrative or judicial ruling to the contrary), for United States
federal income tax purposes to characterize and treat this Security as a prepaid derivative contract that is an “open transaction.”

 

Redemption
and Repayment

 

This
Security is not subject to repayment at the option of the Holder hereof prior to September 11, 2023.  Except as set
forth above under “Automatic Call,” this Security is not subject to redemption prior to September 11, 2023. 
This Security is not entitled to any sinking fund.

 

Acceleration

 

If
an Event of Default, as defined in the Indenture, with respect to this Security shall occur and be continuing, the Maturity
Payment Amount (calculated as set forth in the next sentence) of this Security may be declared due and payable in the manner
and with the effect provided in the Indenture.  The amount payable to the Holder hereof upon any
acceleration permitted under the Indenture will be equal to the Maturity Payment Amount hereof
calculated as provided herein as though the date of acceleration was the Final Calculation Day; provided that if the Closing Level
of the Index on the date of acceleration is equal to or greater than the Starting Level, the amount payable on this Security will
be calculated using a Call Premium that is prorated to the date of acceleration.  

 

 

 

Reference
is hereby made to the further provisions of this Security set forth on the reverse hereof, which further provisions shall for
all purposes have the same effect as if set forth at this place.

 

Unless
the certificate of authentication hereon has been executed by the Trustee referred to on the reverse hereof by manual signature
or its duly authorized agent under the Indenture referred to on the reverse hereof by manual signature, this Security shall not
be entitled to any benefit under the Indenture or be valid or obligatory for any purpose.

 

[The
remainder of this page has been left intentionally blank]

 

    8 

     

    
IN
WITNESS WHEREOF, the Company has caused this instrument to be duly executed.

 

DATED: 

 

	 

	WELLS FARGO FINANCE
LLC

	 

	 

	 

	 

	By:

	 

	 

	 

	 

	 

	 

	 
	Its:
	 

 

	 

	Attest:

	 

	 

	 

	 

	 

	 

	 
	Its: 
	 

 

TRUSTEE’S
CERTIFICATE OF 

AUTHENTICATION 

This
is one of the Securities of the 

series
designated therein described 

in
the within-mentioned Indenture.

 

	CITIBANK, N.A.,

	 

	 

	as Trustee

	 

	 

	 

	 

	By:

	 

	 

	 

	Authorized Signature

	 

	 

	 

	 

	 

	                      OR

	 

	 

	 

	 

	WELLS FARGO BANK,
N.A.,

	 

	 

	as Authenticating
Agent for the Trustee

	 

	 

	 

	 

	By:

	 

	 

	 

	Authorized Signature

	 

 

    9 

     

    
[Reverse
of Note]

 

WELLS
FARGO FINANCE LLC

 

MEDIUM-TERM
NOTE, SERIES A 

Fully
and Unconditionally Guaranteed by Wells Fargo & Company

 

Principal
at Risk Securities Linked to the Dow Jones Industrial Average®
due September 11, 2023

 

This
Security is one of a duly authorized issue of securities of the Company (herein called the “Securities”), issued
and to be issued in one or more series under an indenture dated as of April 25, 2018, as amended or supplemented from time
to time (herein called the “Indenture”), among the Company, as issuer, Wells Fargo & Company, as guarantor
(the “Guarantor”) and Citibank, N.A., as trustee (herein called the “Trustee,” which term
includes any successor trustee under the Indenture), to which Indenture and all indentures supplemental thereto reference is hereby
made for a statement of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Guarantor,
the Trustee and the Holders of the Securities, and of the terms upon which the Securities are, and are to be, authenticated and
delivered.  This Security is one of the series of the Securities designated as Medium-Term Notes, Series A, of the Company. 
The amount payable on the Securities of this series may be determined by reference to the performance of one or more equity-,
commodity- or currency-based indices, exchange traded funds, securities, commodities, currencies, statistical measures of economic
or financial performance, or a basket comprised of two or more of the foregoing, or any other market measure or may bear interest
at a fixed rate or a floating rate.  The Securities of this series may mature at different times, be redeemable at different
times or not at all, be repayable at the option of the Holder at different times or not at all and be denominated in different
currencies.

 

The
Securities are issuable only in registered form without coupons and will be either (a) book-entry securities represented
by one or more Global Securities recorded in the book-entry system maintained by the Depositary or (b) certificated securities
issued to and registered in the names of, the beneficial owners or their nominees.

 

The
Company agrees, to the extent permitted by law, not to voluntarily claim the benefits of any laws concerning usurious rates of
interest against a Holder of this Security.

 

Guarantee

 

The
Securities of this series are fully and unconditionally guaranteed by the Guarantor as and to the extent set forth in the Indenture.

 

Modification
and Waivers 

 

The
Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations
of the Company and the Guarantor and the rights of the Holders of the Securities of each series to be affected under the Indenture
at any time by the

 

    10 

     

    

 

Company, the Guarantor and the Trustee with the consent of the Holders of a majority in principal amount of
the Securities at the time Outstanding of all series to be affected, acting together as a class.  The Indenture also contains
provisions permitting the Holders of a majority in principal amount of the Securities of all series at the time Outstanding affected
by certain provisions of the Indenture, acting together as a class, on behalf of the Holders of all Securities of such series,
to waive compliance by the Company or the Guarantor with those provisions of the Indenture.  Certain past defaults under
the Indenture and their consequences may be waived under the Indenture by the Holders of a majority in principal amount of the
Securities of each series at the time Outstanding, on behalf of the Holders of all Securities of such series.  Solely
for the purpose of determining whether any consent, waiver, notice or other action or Act to be taken or given by the Holders
of Securities pursuant to the Indenture has been given or taken by the Holders of Outstanding Securities in the requisite aggregate
principal amount, the principal amount of this Security will be deemed to be equal to the amount set forth on the face hereof
as the “Face Amount” hereof.  Any such consent or waiver by the Holder of this Security shall be conclusive
and binding upon such Holder and upon all future Holders of this Security and of any Security issued upon the registration of
transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent or waiver is made upon this
Security.

 

Defeasance

 

Section 403
and Article Fifteen of the Indenture and the provisions of clause (ii) of Section 401(1)(B) of the Indenture, relating
to defeasance at any time of (a) the entire indebtedness on this Security and (b) certain restrictive covenants, upon
compliance by the Company or the Guarantor with certain conditions set forth therein, shall not apply to this Security. 
The remaining provisions of Section 401 of the Indenture shall apply to this Security.

 

Authorized
Denominations

 

This
Security is issuable only in registered form without coupons in denominations of $1,000 or any amount in excess thereof which
is an integral multiple of $1,000.

 

Registration
of Transfer

 

Upon
due presentment for registration of transfer of this Security at the office or agency of the Company in the City of Minneapolis,
Minnesota, a new Security or Securities of this series, with the same terms as this Security, in authorized denominations for
an equal aggregate Face Amount will be issued to the transferee in exchange herefor, as provided in the Indenture and subject
to the limitations provided therein and to the limitations described below, without charge except for any tax or other governmental
charge imposed in connection therewith.

 

This
Security is exchangeable for definitive Securities in registered form only if (x) the Depositary notifies the Company that
it is unwilling or unable to continue as Depositary for this Security or if at any time the Depositary ceases to be a clearing
agency registered under the Securities Exchange Act of 1934, as amended, and a successor depositary is not appointed within 90 days
after the Company receives such notice or becomes aware of such ineligibility, (y) the Company in its sole discretion determines
that this Security shall be exchangeable for definitive Securities in registered form and notifies the Trustee thereof or (z)
an Event of Default with respect

 

    11 

     

    
 

to the Securities represented hereby has occurred and is continuing.  If this Security is
exchangeable pursuant to the preceding sentence, it shall be exchangeable for definitive Securities in registered form, having
the same date of issuance, Stated Maturity Date and other terms and of authorized denominations aggregating a like amount. 

 

This
Security may not be transferred except as a whole by the Depositary to a nominee of the Depositary or by a nominee of the Depositary
to the Depositary or another nominee of the Depositary or by the Depositary or any such nominee to a successor of the Depositary
or a nominee of such successor.  Except as provided above, owners of beneficial interests in this Global Security will not
be entitled to receive physical delivery of Securities in definitive form and will not be considered the Holders hereof for any
purpose under the Indenture.

 

Prior
to due presentment of this Security for registration of transfer, the Company, the Guarantor, the Trustee and any agent of the
Company, the Guarantor or the Trustee may treat the Person in whose name this Security is registered as the owner hereof for all
purposes, whether or not this Security be overdue, and neither the Company, the Guarantor, the Trustee nor any such agent shall
be affected by notice to the contrary.

 

Obligation
of the Company Absolute

 

No
reference herein to the Indenture and no provision of this Security or the Indenture shall alter or impair the obligation of the
Company, which is absolute and unconditional, to pay the Maturity Payment
Amount or the Call Price, as applicable, at the times, place and rate, and in the coin or currency, herein prescribed,
except as otherwise provided in this Security.

 

No
Personal Recourse

 

No
recourse shall be had for the payment of the Maturity Payment
Amount or the Call Price, as applicable, or for any claim based hereon, or otherwise in respect hereof, or based on or in respect
of the Indenture or any indenture supplemental thereto, against any incorporator, stockholder, officer or director, as such, past,
present or future, of the Company or any successor corporation or of the Guarantor or any successor corporation, whether by virtue
of any constitution, statute or rule of law, or by the enforcement of any assessment or penalty or otherwise, all such liability
being, by the acceptance hereof and as part of the consideration for the issuance hereof, expressly waived and released.

 

Defined
Terms

 

All
terms used in this Security which are defined in the Indenture shall have the meanings assigned to them in the Indenture unless
otherwise defined in this Security.

 

Governing
Law

 

This
Security shall be governed by and construed in accordance with the law of the State of New York, without regard to principles
of conflicts of laws.

 

    12 

     

    
ABBREVIATIONS

 

The
following abbreviations, when used in the inscription on the face of this instrument, shall be construed as though they were written
out in full according to applicable laws or regulations:

 

	TEN
COM

	--

	as
tenants in common

	 

	 

	 

	TEN
ENT

	--

	as
tenants by the entireties

	 

	 

	 

	JT
TEN

	--

	as
joint tenants with right

of
survivorship and not

as
tenants in common

 

	UNIF
GIFT MIN ACT

	--

	 

	Custodian

	 

	 

	 

	(Cust)

	 

	(Minor)

 

	Under
Uniform Gifts to Minors Act

	 

	 

	 

	(State)

	 

 

Additional
abbreviations may also be used though not in the above list.

 

FOR
VALUE RECEIVED, the undersigned hereby sell(s) and transfer(s) unto

 

	Please
Insert Social Security or

	 

	Other
Identifying Number of Assignee

	 

	 

	 

	 

	 

	 

	 

 

	 

 

 (Please
print or type name and address including postal zip code of Assignee)

 

    13 

     

    
the
within Security of WELLS FARGO FINANCE LLC and does hereby irrevocably constitute and appoint __________________ attorney to transfer
the said Security on the books of the Company, with full power of substitution in the premises. 

	 

	 

	Dated: 
_________________________

	 

	 

	 

	 

	 

	 

	 

 

NOTICE: 
The signature to this assignment must correspond with the name as written upon the face of the within instrument in every particular,
without alteration or enlargement or any change whatever.

 

    14Exhibit 10.12

 

SECURITIES
PURCHASE AGREEMENT

 

This
Securities Purchase Agreement (this “Agreement”) is dated as of November __, 2018, between FMC GlobalSat Holdings,
Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each,
including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”).

 

PREAMBLE

 

WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933,
as amended (the “Securities Act”), and Rule 506 promulgated thereunder, the Company desires to issue and sell
to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company
as more fully described in this Agreement (the “Offering”).

 

NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration,
the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

 

ARTICLE
I.

DEFINITIONS

 

1.1
Definitions. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following
terms have the meanings set forth in this Section 1.1:

 

“Accredited
Investor” shall have the meaning ascribed to it in Section 3.2(c).

 

“Action”
shall have the meaning ascribed to such term in Section 3.1(j).

 

“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.

 

“Board
of Directors” means the board of directors of the Company.

 

“Business
Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or
any day on which banking institutions in the State of New York are authorized or required by law or other governmental action
to close.

 

“Buy-In”
shall have the meaning ascribed to such term in Section 4.1(g).

 

“Closing”
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.

 

“Closing
Date” means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable
parties thereto, and all conditions precedent to (i) the Purchasers’ obligations to pay the Subscription Amount at such
Closing and (ii) the Company’s obligations to deliver the Securities to be issued and sold at such Closing, in each case,
have been satisfied or waived, but in no event later than the third Trading Day following the date hereof in the case of such
Closing.

 

     

     

    

 

“Commission”
means the United States Securities and Exchange Commission.

 

“Common
Stock” means the common stock of the Company, $0.0001 par value, and any other class of securities into which such securities
may hereafter be reclassified or changed.

 

“Common
Stock Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to
acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive,
Common Stock.

 

“Company
Counsel” means such firm or firms as may from time to time provide legal services to the Company.

 

“Disclosure
Schedule” means that certain schedule delivered by the Company to the Purchasers in connection with the execution and
delivery of this Agreement. Except as otherwise noted herein or in the Disclosure Schedule, the Disclosure Schedule and the information
delivered by the Company to the Purchasers therein shall be deemed to include all filings and reports made by the Company with
the Commission whether or not set forth in the Disclosure Schedule.

 

“Escrow
Agent” means Sichenzia Ross Ference LLP and any successor thereto in accordance with the Escrow Agreement.

 

“Escrow
Agreement” means the escrow agreement to be employed in connection with the sale of the Securities and following Closing,
holding of the aggregate Subscription Amount, a copy of which is annexed hereto as Exhibit B.

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

“Exempt
Issuance” means the issuance of (a) shares of Common Stock and options to officers, employees, directors or consultants
of the Company in accordance with a Stock Plan or as otherwise approved by the Board of Directors of the Company, (b) securities
upon the exercise or exchange of any Securities issued hereunder (subject to adjustment for forward and reverse stock splits and
the like that occur after the date hereof) and/or other securities exercisable or exchangeable for or convertible into shares
of Common Stock issued and outstanding on the date of this Agreement, (c) full or partial consideration in connection with a strategic
merger (including a reverse merger), acquisition, consolidation or purchase of securities, debt or assets of a corporation or
other entity which holders of such securities, assets or debt are not issued primarily for the purpose of raising capital, (d)
securities which has been approved by a Majority in Interest, and (e) securities in connection with strategic license agreements
and other partnering arrangements so long as such issuances are not primarily for the purpose of raising capital and which holders
of such securities or debt are not at any time granted registration rights.

 

“GAAP”
shall have the meaning ascribed to such term in Section 3.1(h).

 

“Legend
Removal Date” shall have the meaning ascribed to such term in Section 4.1(d).

 

“Liens”
means a lien, charge pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.

 

    2

     

    

 

“Majority
in Interest” shall have the meaning ascribed to such term in Section 5.5.

 

“Material
Adverse Effect” shall have the meaning assigned to such term in Section 3.1(b).

 

“Maximum
Rate” shall have the meaning ascribed to such term in Section 5.20.

 

“Offering”
shall have the meaning ascribed to such term in the Preamble.

 

“Permitted
Lien” means the individual and collective reference to the following: (A) Liens for taxes, assessments and other governmental
charges or levies not yet due or Liens for taxes, assessments and other governmental charges or levies being contested in good
faith and by appropriate proceedings for which adequate reserves (in the good faith judgment of the management of the Company)
have been established in accordance with GAAP, (B) Liens imposed by law which were incurred in the ordinary course of the Company’s
business, such as carriers’, warehousemen’s and mechanics’ Liens, statutory landlords’ Liens, and other
similar Liens arising in the ordinary course of the Company’s business, and which (x) do not individually or in the aggregate
materially detract from the value of such property or assets or materially impair the use thereof in the operation of the business
of the Company and its consolidated Subsidiaries, or (y) are being contested in good faith by appropriate proceedings, which proceedings
have the effect of preventing for the foreseeable future the forfeiture or sale of the property or asset subject to such Lien,
and (C) Liens incurred prior to or subsequent to the Closing Date.

 

“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

“Proceeding”
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial
proceeding, such as a deposition), whether commenced or threatened.

 

 ”Public
Information Failure” shall have the meaning ascribed to such term in Section 4.2(b).

 

“Public
Information Failure Payments” shall have the meaning ascribed to such term in Section 4.2(b).

 

“Purchaser
Party” shall have the meaning ascribed to such term in Section 4.7.

 

“Required
Approvals” shall have the meaning ascribed to such term in Section 3.1(e).

 

“Rule
144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose
and effect as such Rule.

 

“SEC
Reports” shall mean all reports, schedules, forms, statements and other documents filed by the Company under the Exchange
Act, including pursuant to Section 13(a) or 15(d) thereof, since August 9, 2018, including the exhibits thereto and documents
incorporated by reference therein, which have been available on EDGAR not less than five (5) days before the Closing Date.

 

    3

     

    

 

“Securities”
means the Units, Shares, the Warrants and the Warrant Shares.

 

“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

“Securities
Laws” means the securities laws of the United States or any state thereof and the rules and regulations promulgated
thereunder.

“Shares”
means the shares of Common Stock delivered to the Purchasers pursuant to this Agreement in connection with the Closing.

 

“Stock
Plan” means the Stock Plan of the Company in effect as the date of this Agreement, and as may be amended, supplemented,
revised or replaced, a copy of which and the principal terms of which have been disclosed in the Disclosure Schedule.

 

“Subscription
Amount” means, as to each Purchaser at the Closing, the aggregate amount of cash consideration to be paid for Units
purchased hereunder at the Closing as specified below such Purchaser’s name on the signature page of this Agreement and
next to the heading “Subscription Amount,” in United States dollars and in immediately available funds.

 

“Subsidiary”
means any subsidiary of the Company as set forth on Section 3.1(a) of the Disclosure Schedule and shall, where applicable
and with regard to future events, also include any direct or indirect subsidiary of the Company formed or acquired after the date
hereof.

 

“Termination
Date” shall have the meaning ascribed to such term in Section 2.1(a).

 

“Trading
Day” means a day on which the principal Trading Market is open for trading; provided, that in the event that the Common
Stock is not listed or quoted for trading on a Trading Market on the date in question, then Trading Day shall mean a Business
Day.

 

“Trading
Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on
the date in question: the NYSE MKT, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the
New York Stock Exchange, the OTCQB, the OTCQX or the OTC Pink Open Market (or any successors to any of the foregoing).

 

“Transaction
Documents” means this Agreement, the Escrow Agreement, the Warrants, all exhibits and schedules thereto and hereto and
any other documents or agreements executed in connection with the transactions contemplated hereunder.

 

“Transfer
Agent” means VStock Transfer.

 

“Unit
Purchase Price” means $1.00 per Unit, subject to adjustment for reverse and forward stock splits, stock dividends, and
other similar transactions affecting the Common Stock that occur after the date of this Agreement and prior to Closing.

 

    4

     

    

 

“VWAP”
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then
listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest
preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based
on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the OTC Bulletin Board is not
a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the OTC
Bulletin Board, (c) if the Common Stock is not then listed or quoted for trading on the OTC Bulletin Board and if prices for the
Common Stock are then reported on the OTCQX, OTCQB or OTC Pink Marketplace maintained by the OTC Markets Group, Inc. (or a similar
organization or agency succeeding to its functions of reporting prices), the volume weighted average price of the Common Stock
on the first such facility (or a similar organization or agency succeeding to its functions of reporting prices), or (d) in
all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith
by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.

 

“Warrants”
means, collectively, the Common Stock purchase warrants delivered to the Purchasers at the Closing in the form of Exhibit A
attached hereto.

 

“Warrant
Shares” means the shares of Common Stock issuable upon exercise of the Warrants, provided that any share of Common Stock
issued upon exercise of the Warrants shall not constitute an issued Warrant Share for purposes of this Agreement after such share
has been irrevocably sold pursuant to an effective registration statement under the Securities Act or pursuant to Rule 144 without
further restrictions or conditions to transfer pursuant to Rule 144.

 

ARTICLE
II.

PURCHASE
AND SALE

 

2.1
Closing. On one or more Closing Dates, upon the terms and subject to the conditions set forth herein, provided the Minimum
Amount has been subscribed for, the Company agrees to sell, and each of the Purchasers, severally and not jointly, agrees
to purchase units of the Company’s securities (the “Units”) for an aggregate purchase price of a minimum
(the “Minimum Amount”) of Six Hundred Thousand Dollars ($600,000) and up to a maximum (the “Maximum
Amount”) of One Million Five Hundred Thousand Dollars ($1,500,000), with each Unit consisting of one share of Common
Stock and a Warrant to purchase one half (1/2) share of Common Stock (each such purchase and sale being the “Closing”),
at the Unit Purchase Price. Each Subscriber must purchase a minimum of 25,000 Units (or, $50,000). The Company’s officers
and directors (and/or their Affiliates) may participate in the Offering in an aggregate amount of up to Four Hundred Thousand
Dollars ($400,000) which such amount shall be applied towards the Minimum Amount and Maximum Amount. Prior to the Closing, each
Purchaser shall deliver to the Escrow Agent, inter alia, such Purchaser’s Subscription Amount as set
forth on the signature page hereto executed by such Purchaser by a wire transfer of immediately available funds, and the Company
shall, on the Closing Date, cause the Company to deliver to each Purchaser, inter alia, a certificate representing
the number of Shares and Warrants purchased by each such Purchaser at the Closing as determined pursuant to Section 2.2(a). The
Company and each Purchaser shall also deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction
of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closings shall occur at the offices of Company Counsel
or such other location as the parties shall mutually agree. Notwithstanding anything herein to the contrary, each Closing Date
shall occur on or before November 15, 2018, which may be extended at the discretion of the Company’s Board of Directors
for up to an additional thirty (30) days (such outside date, “Termination Date”). If any Closing is not held
on or before the Termination Date, (i) all subscription documents executed by the Company or a Purchaser shall be returned to
the Company or such Purchaser, as applicable, and (ii) each Subscription Amount shall be returned, without interest or deduction
to the Purchaser who delivered such Subscription Amount.

 

    5

     

    

 

2.2
Deliveries.

 

(a)
On the Closing Date, the Company shall deliver or cause to be delivered to the Purchasers the following:

 

(i)
this Agreement and the Escrow Agreement each duly executed by the Company;

 

(ii)
certificates for Shares and Warrants evidencing a number of Units equal to such Purchaser’s Subscription Amount divided
by the Unit Purchase Price registered in the name of such Purchaser, which, in the case of the Shares, may also be delivered in
book entry form;

  

(b)
On or prior to the applicable Closing Date, each Purchaser shall deliver or cause to be delivered to the Escrow Agent pursuant
to the Escrow Agreement the following:

 

(i)
such Purchaser’s Subscription Amount by wire transfer to the Escrow Agent; and

 

(ii)
this Agreement and the Escrow Agreement, each duly executed by such Purchaser.

 

2.3
Closing Conditions.

 

(a)
The obligations of the Company hereunder in connection with the Closing, unless waived, are subject to the following conditions
being met:

 

(i)
the accuracy in all material respects when made and on the Closing Date of the representations and warranties of the Purchasers
contained herein (unless as of a specific date therein in which case they shall be accurate as of such date);

 

(ii)
all conditions, obligations, covenants and agreements of each Purchaser under this Agreement required to be performed at or prior
to the Closing Date shall have been performed in all material respects;

 

(iii)
the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement; and

 

(iv)
receipt by the Escrow Agent of an aggregate Subscription Amount equal to at least the Minimum Amount.

 

(b)
The respective independent obligations of a Purchaser hereunder in connection with the Closing, unless waived by such Purchaser,
are subject to the following conditions being met:

 

(i)
the accuracy in all material respects (when made and on the Closing Date of the representations and warranties of the Company
contained herein (unless as of a specific date therein in which case they shall be accurate as of such date);

 

    6

     

    

 

(ii)
all Required Approvals, obligations, covenants and agreements of the Company under this Agreement required to be performed at
or prior to the Closing Date shall have been performed;

 

(iii)
the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;

 

(v)
there shall have been no Material Adverse Effect with respect to the Company since the date hereof and the Closing Date; and

 

(vi)
receipt by the Escrow Agent of an aggregate Subscription Amount equal to at least the Minimum Amount.

 

ARTICLE
III.

REPRESENTATIONS
AND WARRANTIES

 

3.1
Representations and Warranties of the Company. Except as set forth in the Disclosure Schedule, which Disclosure Schedule
shall be deemed a part hereof, the Company hereby makes the following representations and warranties to each Purchaser as of the
date of this Agreement and as of the Closing Date:

 

(a)
Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth on Section 3.1(a) of the
Disclosure Schedule. The Company owns, directly or indirectly, a majority of the capital stock or other equity interests of each
Subsidiary free and clear of any Liens, other than Permitted Liens, subject to restrictions under applicable laws, and all of
the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and
free of preemptive and similar rights to subscribe for or purchase securities.

 

(b)
Organization and Qualification. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized,
validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite
power and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the
Company nor any Subsidiary is in violation or default of any of the provisions of its respective certificate or articles of incorporation,
bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business
and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted
or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as
the case may be, could not reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability
of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition
(financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company’s
ability to perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii)
or (iii), a “Material Adverse Effect”) and to the best of the Company’s knowledge no Proceeding has been
instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority
or qualification.

 

    7

     

    

 

(c)
Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate
the transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations
hereunder and thereunder. The execution and delivery of each of this Agreement and the other Transaction Documents by the Company
and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action
on the part of the Company and no further action is required by the Company, the Board of Directors or the Company’s stockholders
in connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction
Document to which it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in
accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against
the Company in accordance with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency,
reorganization, moratorium, liquidation and other laws of general application affecting enforcement of creditors’ rights
generally, and (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable
remedies.

 

(d)
No Conflicts. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents
to which it is a party, the issuance and sale of the Units and the consummation by it of the transactions contemplated hereby
and thereby do not and will not: (i) conflict with or violate any provision of the Company’s or any Subsidiary’s certificate
or articles of incorporation, bylaws or other organizational or charter documents, (ii) conflict with, or constitute a default
(or an event that with notice or lapse of time or both would become a default) by the Company or any Subsidiary under, result
in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights
of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit
facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the
Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected,
or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment,
injunction, decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject
(including Securities Laws), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in
the case of each of clauses (ii) and (iii), such as reasonably be expected to result in a Material Adverse Effect.

 

(e)
Filings, Consents and Approvals. Except as disclosed on Section 3.1(e) of the Disclosure Schedule, the Company is not required
to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court
or other provincial or foreign or domestic federal, state, local or other governmental authority or other Person in connection
with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required
pursuant to Section 4.4 of this Agreement and (ii) the filing of a Form D with the Commission and related “blue sky”
filings, if applicable (collectively, the “Required Approvals”).

 

(f)
Issuance of the Securities. The Securities are restricted securities and have been duly authorized and, when issued and
paid for in accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable,
free and clear of all Liens other than restrictions on transfer provided for under the Securities Act, the Exchange Act, in the
Transaction Documents and as provided herein.

 

    8

     

    

 

(g)
Capitalization. The capitalization of the Company is as set forth in Section 3.1(g) of the Disclosure Schedule. The Company
has not issued any capital stock since its most recently filed report under the Exchange Act, other than pursuant to the exercise
of employee stock options under the Stock Plans, the issuance of shares of Common Stock to employees pursuant to the Stock Plans
and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently filed
periodic report under the Exchange Act. Except as set forth in Section 3.1(g) of the Disclosure Schedule, no Person has any right
of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated
by the Transaction Documents. Except as disclosed on Section 3.1(g) of the Disclosure Schedule, there are no outstanding options,
warrants, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations
convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire any shares of
Common Stock, or material contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or
may become bound to issue additional shares of Common Stock or Common Stock Equivalents. Except as set forth on Section 3.1(g)
of the Disclosure Schedule, the issuance and sale of the Units will not obligate the Company to issue shares of Common Stock or
other securities to any Person (other than the Purchasers) and will not result in a right of any holder of Company securities
to adjust the exercise, conversion, exchange or reset price under any of such securities. All of the outstanding shares of capital
stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in material compliance
with all federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights
or similar rights to subscribe for or purchase securities. No further approval or authorization of any stockholder, the Board
of Directors or others is required for the issuance and sale of the Units. Except as disclosed on Section 3.1(g) of the Disclosure
Schedule, there are no stockholders agreements, voting agreements or other similar agreements with respect to the Company’s
capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Company’s
stockholders.

 

(h)
Form 8-K; Financial Statements. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Sections 12(b), 12(g), 13(a) or
15(d) thereof, since August 9, 2018. The Form 8-K described in Section 4.4, upon its filing, will comply in all material respects
with the requirements of the Exchange Act, and will not contain any untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under
which they were made, not misleading. The latest audited financial statements of the Company included in the SEC Reports, if any,
comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect
thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with United States generally
accepted accounting principles applied on a consistent basis during the periods involved (“GAAP”), except as
may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may
not contain all footnotes required by GAAP and are subject to normal, immaterial, year-end audit adjustments, and fairly present
in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof
and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal,
immaterial, year-end audit adjustments.

 

    9

     

    

 

(i)
Material Changes; Undisclosed Events, Liabilities or Developments. Except as disclosed in Section 3.1(i) of the Disclosure
Schedule, since June 30, 2018, except as specifically disclosed in a subsequent SEC Report filed not later than five (5) Trading
Days prior to the date hereof: (i) there has been no event, occurrence or development that has had or that could reasonably be
expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other
than (A) trade payables, and accrued expenses incurred in the ordinary course of business consistent with past practice, (B) transaction
expenses incurred in connection with the Transaction Documents, and (C) liabilities not required to be reflected in the Company’s
financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Company has not altered its
method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property to its
stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock and (v) the Company
has not issued any equity securities to any officer, director or Affiliate. The Company does not have pending before the Commission
any request for confidential treatment of information. Except for the issuance of the Securities contemplated by this Agreement
or as disclosed on Section 3.1(i) of the Disclosure Schedule, no event, liability, fact, circumstance, occurrence or development
has occurred or exists, or is reasonably expected to occur or exist, with respect to the Company or its Subsidiaries or their
respective businesses, properties, operations, assets or financial condition, that would be required to be disclosed by the Company
under applicable Securities Laws at the time this representation is made or deemed made that has not been publicly disclosed at
least one (1) Trading Day prior to the date that this representation is made.

 

(j)
Litigation. Except as set forth in Section 3.1(j) of the Disclosure Schedule, to the knowledge of the Company, there is
no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened
against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental
or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an “Action”)
that would, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect, nor
to the knowledge of the Company is there any reasonable basis for any such Action that would, if there were an unfavorable decision,
have or reasonably be expected to result in a Material Adverse Effect. To the knowledge of the Company, there is not pending or
contemplated, any investigation by the Commission involving the Company or, to the knowledge of the Company, any current or former
director or officer of the Company, nor any current or former officer, director, control person, principal shareholder, or creditor
with respect to the relationship of any of the foregoing to the Company. The Commission has not issued any stop order or other
order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act
or the Securities Act.

 

(k)
Compliance. To the knowledge of the Company, neither the Company nor any Subsidiary: (i) is in default under or in violation
of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by
the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default under
or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party
or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation
of any judgment, decree or order of any court, arbitrator or other governmental authority or (iii) is or has been in violation
of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal,
state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and
employment and labor matters, except in each case as would not reasonably be expected to result in a Material Adverse Effect.

 

    10

     

    

 

(m)
Title to Assets. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned
by them and good and marketable title in all personal property owned by them that is material to the business of the Company and
the Subsidiaries, in each case free and clear of all Liens, except for Permitted Liens. Any real property and facilities held
under lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the
Company and the Subsidiaries are in compliance, except where the non-compliance would not reasonably be expected to result in
a Material Adverse Effect.

 

(n)
Intellectual Property. For purposes of this Section 3.1(n), Company shall mean Company and each Subsidiary, as applicable.

 

(i)
The term “Intellectual Property Rights” includes the name of the Company, all fictional business names, trading
names, registered and unregistered trademarks, service marks, and applications (collectively, “Marks’’),
owned, used, or licensed by the Company as licensee or licensor.

 

(ii)Agreements.
Section 3.1(n) of the Disclosure Schedule contains a complete and accurate list of all material contracts relating to the Company’s
Intellectual Property Rights to which the Company is a party or by which the Company is bound, except for any license implied
by the sale of a product and perpetual, paid-up licenses for commonly available software programs with a value of less than $100,000
under which the Company is the licensee. There are no outstanding and, to Company’s knowledge, no threatened disputes or
disagreements with respect to any such agreement.

 

(iii)
Know-How Necessary for the Business. To the Company’s knowledge: the Company’s Intellectual Property Rights
are all those necessary for the operation of the Company’s businesses as it is currently conducted or as represented, in
writing, to the Purchasers to be conducted. To the Company’s knowledge: the Company is the owner of all right, title, and
interest in and to each of the Intellectual Property Rights, free and clear of all liens, security interests, charges, encumbrances,
equities, and other adverse claims, and has the right to use all of the Intellectual Property Rights, subject in each case to
Permitted Liens.

 

(o)
Transactions With Affiliates and Employees. Except as set forth in Section 3.1(o) of the Disclosure Schedule, none of the
officers or directors of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company
or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other than for services as employees,
officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or
by, providing for rental of real or personal property to or from, providing for the borrowing of money from or lending of money
to or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any
entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder,
member or partner, in each case in excess of $250,000 other than for: (i) payment of salary or consulting fees for services rendered,
(ii) reimbursement for expenses incurred on behalf of the Company or in accordance with the past practices of the Company and
(iii) other employee benefits, including stock option agreements under the Stock Plan.

 

    11

     

    

 

(p)
Certain Fees. Except as set forth in Section 3.1(p) of the Disclosure Schedule, no brokerage, finder’s fees, commissions
or due diligence fees are or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant,
finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction
Documents. The Purchaser shall have no obligation with respect to any fees or with respect to any claims made by or on behalf
of other Persons for fees of a type contemplated in this Section 3.1(p) that may be due in connection with the transactions contemplated
by the Transaction Documents other than any fees or obligations incurred by the Purchaser.

 

(q)
Private Placement. Assuming the accuracy of the Purchasers’ representations and warranties set forth in Section 3.2,
registration under the Securities Act is not required for the offer and sale of the Units by the Company to the Purchasers as
contemplated hereby.

 

(r)
Investment Company. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Units,
will not be or be an Affiliate of, an “investment company” within the meaning of the Investment Company Act of 1940,
as amended. 

 

(s)
Registration Rights. Except as set forth in Section 3.1(s) of the Disclosure Schedule, no Person has any right to cause
the Company to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.

 

(t)
Disclosure. All of the disclosure in the SEC Reports, is true and correct in all material respects and does not contain
any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements made therein,
in light of the circumstances under which they were made, not misleading. The Company acknowledges and agrees that no Purchaser
makes or has made any representations or warranties with respect to the transactions contemplated hereby other than those specifically
set forth in Section 3.2 hereof.

 

(u)
No Integrated Offering. Assuming the accuracy of the Purchasers’ representations and warranties set forth in Section
3.2, neither the Company, nor, to the knowledge of the Company, any of its Affiliates, nor any Person acting on its or, to the
knowledge of the Company, their behalf has, directly or indirectly, made any offers or sales of any security or solicited any
offers to buy any security, under circumstances that would cause this offering of the Units by the Company to be integrated with
prior offerings by the Company for purposes of (i) the Securities Act which would require the registration of any such securities
under the Securities Act, or (ii) any applicable shareholder approval provisions of any Trading Market on which any of the securities
of the Company are listed or designated.

 

 (v)
Accountants. The Company’s accounting firm is set forth on Section 3.1(v) of the Disclosure Schedule. To the knowledge
and belief of the Company, such accounting firms are registered with the Public Company Accounting Oversight Board, and shall
express its opinion with respect to the financial statements to be included in the Company’s Annual Report for the fiscal
year ending December 31, 2018.

 

    12

     

    

 

3.2
Representations and Warranties of the Purchasers. Each Purchaser, for itself and for no other Purchaser, hereby represents
and warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein):

 

(a)
Organization; Authority. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership,
limited liability company or similar power and authority to enter into and to consummate the transactions contemplated by the
Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction
Documents and performance by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized
by all necessary corporate, partnership, limited liability company or similar action, as applicable, on the part of such Purchaser.
Each Transaction Document to which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser
in accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against
it in accordance with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency,
reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii)
as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii)
insofar as indemnification and contribution provisions may be limited by applicable law. If such Purchaser is an entity, the address
of its principal place of business is as set forth on the signature page hereto, and if such Purchaser is an individual, the address
of its principal residence is as set forth on the signature page hereto.

 

(b)
Understandings or Arrangements. Such Purchaser understands that the Securities are “restricted securities”
and have not been registered under the Securities Act or any applicable state securities law and is acquiring the Securities as
principal for its own account and not with a view to or for distributing or reselling such Securities or any part thereof in violation
of the Securities Act or any applicable state securities law, has no present intention of distributing any of such Securities
in violation of the Securities Act or any applicable state securities law and has no direct or indirect arrangement or understandings
with any other persons to distribute or regarding the distribution of such Securities in violation of the Securities Act or any
applicable state securities law (this representation and warranty not limiting such Purchaser’s right to sell the Securities
pursuant to a registration statement or otherwise in compliance with applicable federal and state securities laws). Such Purchaser
is acquiring the Securities hereunder in the ordinary course of its business.

 

(c)
Purchaser Status. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on
each date on which it exercises any Warrants it will be either: (i) an “accredited investor” as defined in Rule 501(a)(1),
(a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act or (ii) a “qualified institutional buyer” as defined in
Rule 144A(a) under the Securities Act. Such Purchaser is not required to be registered as a broker-dealer under Section 15 of
the Exchange Act. Such Purchaser has the authority and is duly and legally qualified to purchase and own the Securities. Such
Purchaser is able to bear the risk of such investment for an indefinite period and to afford a complete loss thereof. Such Purchaser
has provided the information in the Accredited Investor Questionnaire attached hereto as Exhibit C (the “Investor
Questionnaire”). The information set forth on the signature pages hereto and the Investor Questionnaire regarding such
Purchaser is true and complete in all respects. Except as disclosed in the Investor Questionnaire, such Purchaser has had no position,
office or other material relationship within the past three years with the Company or Persons (as defined below) known to such
Purchaser to be affiliates of the Company, and is not a member of the Financial Industry Regulatory Authority or an “associated
person” (as such term is defined under the FINRA Membership and Registration Rules Section 1011).

 

    13

     

    

 

(d) Experience
of Such Purchaser. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and
experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk
of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.

 

(e)
Information on Company. Such Purchaser has been furnished with or has had access to the EDGAR Website of the Commission
to the Company’s filings made with the Commission during the period beginning on August 9, 2018 and continuing through the
tenth business day preceding the Closing Date in which such Purchaser purchases Securities hereunder, including but not limited
to the Risk Factor section of the SEC Reports. Purchasers are not deemed to have any knowledge of any information not included
in the Disclosure Schedule unless such information is delivered in the manner described in the next sentence. In addition, such
Purchaser may have received in writing from the Company such other information concerning its operations, financial condition
and other matters as such Purchaser has requested, identified thereon as OTHER WRITTEN INFORMATION (such other information is
collectively, the “Other Written Information”), and considered all factors such Purchaser deems material in
deciding on the advisability of investing in the Securities. Such Purchaser was afforded (i) the opportunity to ask such questions
as such Purchaser deemed necessary of, and to receive answers from, representatives of the Company concerning the merits and risks
of acquiring the Securities; (ii) the right of access to information about the Company and its financial condition, results of
operations, business, properties, management and prospects sufficient to enable such Purchaser to evaluate the Securities; and
(iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort
or expense that is necessary to make an informed investment decision with respect to acquiring the Securities. Purchaser acknowledges
and confirms that the Common Stock is not presently traded on any market or securities exchange and, as of the date hereof, the
Company has not applied for listing or quotation on any exchange. The Purchaser understands that the Company is currently seeking
sponsorship for the trading of its Common Stock on the OTC QB or other over-the-counter trading platform. The Purchaser further
acknowledges that there can be no assurance that a market maker will agree to file the necessary documents with FINRA, nor can
the Company provide any assurance that the Common Stock will actually be quoted on the OTC QB or other over-the-counter trading
platform or, if quoted, that a viable public market will materialize.

 

(f)
Certain Transactions and Confidentiality. Such Purchaser understands and agrees that the Securities have not been registered
under the Securities Act or any applicable state securities laws, by reason of their issuance in a transaction that does not require
registration under the Securities Act, and that such Securities must be held indefinitely unless a subsequent disposition is registered
under the Securities Act or any applicable state securities laws or is exempt from such registration. Such Purchaser understands
and agrees that the Securities are being offered and sold to such Purchaser in reliance on specific exemptions from the registration
requirements of United States federal and state securities laws and regulations and that the Company is relying in part upon the
truth and accuracy of, and such Purchaser’s compliance with, the representations, warranties, agreements, acknowledgments
and understandings of such Purchaser set forth herein in order to determine the availability of such exemptions and the eligibility
of such Purchaser to acquire the Securities.

 

    14

     

    

 

(g)
Communication of Offer. Such Purchaser is not purchasing the Securities as a result of any “general solicitation”
or “general advertising,” as such terms are defined in Regulation D, which includes, but is not limited to, any advertisement,
article, notice or other communication regarding the Securities published in any newspaper, magazine or similar media or on the
internet or broadcast over television, radio or the internet or presented at any seminar or any other general solicitation or
general advertisement.

 

(h)
No Governmental Review. Such Purchaser understands that no United States federal or state agency or any other governmental
or state agency has passed on or made recommendations or endorsement of the Securities or the suitability of the investment in
the Securities nor have such authorities passed upon or endorsed the merits of the offering of the Securities.

 

(i)
No Conflicts. The execution, delivery and performance of this Agreement and performance under the other Transaction Documents
and the consummation by such Purchaser of the transactions contemplated hereby and thereby or relating hereto or thereto do not
and will not (i) result in a violation of such Purchaser’s charter documents, bylaws or other organizational documents,
if applicable, (ii) conflict with nor constitute a default (or an event which with notice or lapse of time or both would become
a default) under any agreement to which such Purchaser is a party, nor (iii) result in a violation of any law, rule, or regulation,
or any order, judgment or decree of any court or governmental agency applicable to such Purchaser or its properties (except for
such conflicts, defaults and violations as would not, individually or in the aggregate, have a material adverse effect on such
Purchaser). Such Purchaser is not required to obtain any consent, authorization or order of, or make any filing or registration
with, any court or governmental agency in order for it to execute, deliver or perform any of its obligations under this Agreement
or perform under the other Transaction Documents nor to purchase the Securities in accordance with the terms hereof, provided
that for purposes of the representation made in this sentence, such Purchaser is assuming and relying upon the accuracy of the
relevant representations and agreements of the Company herein.

 

(j)
Pre-Existing Relationships. The Purchaser represents and warrants that: (i) the Purchaser has a prior substantial pre-existing
relationship with the Company, the Purchaser is not investing in the Offering in connection with or as a result of any registration
statement filed with the Commission by the Company and (ii) no Securities were offered or sold to it by means of any form
of general solicitation or general advertising, and in connection therewith, the Purchaser did not (A) receive or review any advertisement,
article, notice or other communication published in a newspaper or magazine or similar media or broadcast over television or radio,
whether closed circuit, or generally available; or (B) attend any seminar meeting or industry investor conference whose attendees
were invited by any general solicitation or general advertising; or (C) observe any website or filing of the Company with the
Commission in which any offering of securities by the Company was described and as a result learned of any offering of securities
by the Company.

 

(k)
Survival. The foregoing representations and warranties shall survive the Closing Date.

 

The
Company acknowledges and agrees that the representations contained in Section 3.2 shall not modify, amend or affect such Purchaser’s
right to rely on the Company’s representations and warranties contained in this Agreement or any representations and warranties
contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this
Agreement or the consummation of the transaction contemplated hereby.

 

    15

     

    

 

ARTICLE
IV.

OTHER
AGREEMENTS OF THE PARTIES

 

4.1
Transfer Restrictions.

 

(a)
Securities Laws. The Securities may only be disposed of in compliance with state and federal securities laws. In connection
with any transfer of Securities other than pursuant to an effective registration statement or Rule 144, to the Company or to an
Affiliate of a Purchaser or in connection with a pledge as contemplated in Section 4.1(c), the Company may require the transferor
thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the
form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not
require registration of such transferred Securities under the Securities Act. As a condition of such transfer, any such transferee
shall agree in writing to be bound by the terms of this Agreement and shall have the rights and obligations of a Purchaser under
this Agreement and the other Transaction Documents.

 

(b)
Legend. The Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities
in the following form:

 

[NEITHER]
THIS SECURITY [NOR THE SECURITIES [FOR] WHICH THIS SECURITY IS EXERCISABLE] HAS [NOT] BEEN REGISTERED WITH THE SECURITIES AND
EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES
ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) AND APPLICABLE STATE SECURITIES LAWS, AND, ACCORDINGLY, MAY NOT BE
OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION
FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE
STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL
BE REASONABLY ACCEPTABLE TO THE COMPANY. TO THE EXTENT PERMITTED BY APPLICABLE SECURITIES LAWS, THIS SECURITY [AND THE SECURITIES
ISSUABLE UPON EXERCISE OF THIS SECURITY] MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER
OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES
ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

(c)
Pledge. The Company acknowledges and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin
agreement with a registered broker-dealer or grant a security interest in some or all of the Securities to a financial institution
that is an “accredited investor” as defined in Rule 501(a) under the Securities Act and who agrees to be bound by
the provisions of this Agreement and, if required under the terms of such arrangement, such Purchaser may transfer pledge or secure
Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company and no
legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no
notice shall be required of such pledge. At such Purchaser’s expense, the Company will execute and deliver such reasonable
documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the
Securities including, if the Securities are subject to registration, the preparation and filing of any required prospectus supplement
under Rule 424(b)(3) under the Securities Act or other applicable provision of the Securities Act to appropriately amend the list
of selling stockholders thereunder.

 

    16

     

    

 

(d)Legend
Removal.Certificates issued for Shares and Warrant Shares shall not contain any legend (including the legend set forth
in Section 4.1(b) hereof) except for the legend set forth in Section 2.4(c), if applicable: (i) while a registration statement
covering the resale of such security is effective under the Securities Act, (ii) following any sale of such Shares and Warrant
Shares pursuant to Rule 144, or (iii) if such legend is not required under applicable requirements of the Securities Act (including
judicial interpretations and pronouncements issued by the staff of the Commission). If all or any portion of a Warrant is exercised
at a time when there is an effective registration statement to cover the resale of the Shares or Warrant Shares, or if such Shares
or Warrant Shares, as applicable, may be sold under Rule 144 or if such legend is not otherwise required under applicable requirements
of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission) then such
Shares or Warrant Shares, as applicable, shall be issued free of all legends. The Company agrees that following such time as such
legend is no longer required under this Section 4.1(d), upon written request of a Purchaser, no later than five (5) Trading Days
following the delivery by a Purchaser to the Company or the Transfer Agent of a certificate representing the Shares or Warrant
Shares, as applicable, issued with a restrictive legend (such fifth Trading Day, the “Legend Removal Date”),
use its reasonable best efforts to deliver or cause to be delivered to such Purchaser a certificate representing such shares that
is free from all restrictive legends (however, the Company shall use reasonable best efforts to deliver such shares within three
(3) Trading Days). The Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge
the restrictions on transfer set forth in this Section 4 without reasonable basis communicated to Purchaser in writing no later
than five (5) Trading days from such instruction. In lieu of delivering physical certificates representing the unlegended shares,
upon request of a Purchaser, on or after the Liquidity Date (as defined below) so long as the certificates therefor do not bear
a legend and the Purchaser is not obligated to return such certificate for the placement of a legend thereon, the Company shall
cause its transfer agent to electronically transmit the unlegended shares by crediting the account of Purchaser’s broker
with the Depository Trust Company through its Deposit Withdrawal At Custodian system, provided that the Company’s Common
Stock is DTC eligible and the Company’s transfer agent participates in the Deposit Withdrawal at Custodian system. Such
delivery must be made on or before the Legend Removal Date.

 

(e)
Legend Removal Default. On or after the date that a market maker has submitted and FINRA has approved an application pursuant
to Rule 15c-211 of the Exchange Act and the Common Stock is subsequently quoted or trading on a trading platform or securities
exchange (such date, the “Liquidity Date”), in the event of a willful failure to conform to the requirements
of Section 4.1(d) above, in addition to such Purchaser’s other available remedies, the Company shall pay to a Purchaser,
in cash, as partial liquidated damages and not as a penalty, for each $1,000 of Shares or Warrant Shares (based on the greater
of the VWAP of the Common Stock on the date such Securities are submitted to the Transfer Agent or the aggregate purchase price
of such Shares and Warrant Shares) delivered for removal of the restrictive legend, subject to Section 4.1(d), $10 per Trading
Day for each Trading Day following the Legend Removal Date until such Common Stock certificate is delivered without a legend.
Nothing herein shall limit such Purchaser’s right to pursue actual damages for the Company’s failure to deliver certificates
representing any Securities as required by the Transaction Documents, and such Purchaser shall have the right to pursue all remedies
available to it at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief.
Notwithstanding anything herein to the contrary, Legend Removal Default or Buy-In amounts shall not accrue or be payable at any
time that the applicable accounting standards under GAAP would require derivative accounting treatment for such payments.

 

    17

     

    

 

(f)
Injunction. In the event a Purchaser shall request delivery of Shares or Warrant Shares as described in this Section 4.1
and the Company is required to deliver such Securities, the Company may not refuse to deliver such Securities based on any claim
that such Purchaser or anyone associated or affiliated with such Purchaser has not complied with Purchaser’s obligations
under the Transaction Documents, unless, an injunction or temporary restraining order from a court, on notice, restraining and
or enjoining delivery of such unlegended shares shall have been sought and obtained by the Company and the Company has posted
a surety bond for the benefit of such Purchaser in the amount of the greater of (i) 120% of the amount of the aggregate purchase
price of the Shares and Warrant Shares which are subject to the injunction or temporary restraining order, or (ii) the VWAP of
the Common Stock on the trading day before the issue date of the injunction multiplied by the number of Shares and Warrant Shares
to be subject to the injunction, which bond shall remain in effect until the completion of arbitration/litigation of the dispute
and the proceeds of which shall be payable to such Purchaser to the extent Purchaser obtains judgment in Purchaser’s favor.

 

(g)
Buy-In. On or after the Liquidity Date, in the event a Purchaser shall request delivery of Shares or Warrant Shares as
described in this Section 4.1 and the Company is required to deliver Shares or Warrant Shares in addition to any other rights
available to Purchaser, if the Company willfully fails to deliver to a Purchaser Shares or Warrant Shares as required pursuant
to this Agreement and after the Legend Removal Date, the Purchaser, or a broker on the Purchaser’s behalf, purchases (in
an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser which the
Purchaser was entitled to receive in unlegended form from the Company (a “Buy-In”), provided however, that
Purchaser’s sales were made on the reasonable belief that Purchaser was entitled to and Company was obligated to remove
such legend and deliver the Purchaser such shares then the Company shall promptly pay in cash to the Purchaser (in addition to
any remedies available to or elected by the Purchaser) the amount, if any, by which the Purchaser’s total purchase price
(including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds the aggregate purchase price of
the shares of Common Stock delivered to the Company for reissuance as unlegended Shares, (which amount shall be paid as liquidated
damages and not as a penalty). For example, if a Purchaser purchases shares of Common Stock having a total purchase price of $11,000
to cover a Buy-In with respect to $10,000 of purchase price of shares of Common Stock delivered to the Company for reissuance
as unlegended shares, the Company shall be required to pay the Purchaser $1,000, plus interest, if any. The Purchaser shall provide
the Company written notice indicating the amounts payable to the Purchaser in respect of the Buy-In.

 

4.2
Furnishing of Information; Public Information.

 

(a)
Until the earliest of the time that (i) no Purchaser owns any Securities, or (ii) the Warrants have expired, the Company covenants
to maintain the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange Act and to timely file (or obtain
extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after
the date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange
Act.

 

    18

     

    

 

(b)
At any time commencing on the Liquidity Date and ending at such time that all of the Shares or Warrant Shares may be sold without
restriction or the requirement for the Company to be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation
pursuant to Rule 144, if the Company shall fail for any reason to satisfy the current public information requirement under Rule
144(c) (a “Public Information Failure”) then, in addition to such Purchaser’s other available remedies,
the Company shall pay to a Purchaser, in cash, as partial liquidated damages and not as a penalty, by reason of any such delay
in or reduction of its ability to sell the Securities, an amount in cash equal to 1.0% of the aggregate Subscription Amount of
Units then held by such Purchaser on every thirtieth (30th) day (pro-rated for periods totaling less than thirty days) thereafter
until the earlier of (a) the date such Public Information Failure is cured and (b) such time that such public information is no
longer required for the Purchasers to transfer the Shares or Warrant Shares pursuant to Rule 144 (but not more than 6.0% in the
aggregate). The payments to which a Purchaser shall be entitled pursuant to this Section 4.2(b) are referred to herein as “Public
Information Failure Payments.” Public Information Failure Payments shall be paid on the earlier of (i) the last day
of the calendar month during which such Public Information Failure Payments are incurred and (ii) the third (3rd) Business Day
after the event or failure giving rise to the Public Information Failure Payments is cured. In the event the Company fails to
make Public Information Failure Payments in a timely manner, such Public Information Failure Payments shall bear interest at the
rate of 1% per month (prorated for partial months) until paid in full. Nothing herein shall limit such Purchaser’s right
to pursue actual damages for the Public Information Failure, and such Purchaser shall have the right to pursue all remedies available
to it at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief. Notwithstanding
anything herein to the contrary, Public Information Failure Payments shall not accrue or be payable at any time that the applicable
accounting standards under GAAP would require derivative accounting treatment for such liquidated damages.

 

4.3
Integration. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any
security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Units by the Company
in a manner that would require the registration under the Securities Act of the sale of the Units or that would be integrated
with the offer or sale of the Units for purposes of the rules and regulations of any Trading Market such that it would require
shareholder approval prior to the closing of such other transaction unless shareholder approval is obtained before the closing
of such subsequent transaction.

 

4.4
Securities Laws Disclosure; Publicity. The Company shall file a Current Report on Form 8-K including the Transaction Documents
as exhibits thereto within the time period required by the Exchange Act. Notwithstanding the foregoing, the Company shall not
publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission or any regulatory
agency or Trading Market unless the name of such Purchaser is already included in the body of the Transaction Documents, without
the prior written consent of such Purchaser, except: (a) as required by federal securities law in connection with the filing of
final Transaction Documents with the Commission and (b) to the extent such disclosure is required by law or Trading Market regulations.

 

4.4
Use of Proceeds. The Company will use the net proceeds to the Company from the sale of the Units hereunder as set forth
in Section 4.5 of the Disclosure Schedule.

 

    19

     

    

 

4.6
Indemnification of Purchasers. Subject to the provisions of this Section 4.6, the Company will indemnify and hold each
Purchaser and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally
equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls
such Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors,
officers, shareholders, agents, members, partners or employees (and any other Persons with a functionally equivalent role of a
Person holding such titles notwithstanding a lack of such title or any other title) of such controlling persons (each, a “Purchaser
Party”) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses,
including all judgments, amounts paid in settlements (provided the defense of such matter and settlement has been approved by
the Company, which approval will not be unreasonably withheld), court costs and reasonable attorneys’ fees of a single counsel
for representation of all of the Purchaser Parties collectively and costs of investigation that any such Purchaser Party may suffer
or incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made
by the Company in this Agreement or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties
in any capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such
Purchaser Party, with respect to any of the transactions contemplated by the Transaction Documents (unless such action is based
upon a breach of such Purchaser Party’s representations, warranties or covenants under the Transaction Documents or any
agreements or understandings such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party
of Securities Laws or any conduct by such Purchaser Party which constitutes fraud, gross negligence, willful misconduct or malfeasance).
If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement,
such Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to assume the defense
thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right
to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel
shall be at the expense of such Purchaser Party except to the extent that (i) the employment thereof has been specifically authorized
by the Company in writing, (ii) the Company has failed after a reasonable period of time to assume such defense and to employ
counsel or (iii) in such action there is, in the reasonable opinion of such Purchaser Party’s counsel, a material conflict
on any material issue between the position of the Company and the position of such Purchaser Party, in which case the Company
shall be responsible for the reasonable fees and expenses of no more than one such separate counsel for all Purchaser Parties.
The Company will not be liable to any Purchaser Party under this Agreement (iv) for any settlement by a Purchaser Party effected
without the Company’s prior written consent, which shall not be unreasonably withheld, conditioned or delayed; or (v) to
the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party’s breach
of any of the representations, warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other
Transaction Documents. The indemnification required by this Section 4.6 shall be made by periodic payments of the amount thereof
during the course of the investigation or defense, as and when bills are received or are incurred. The indemnity agreements contained
herein shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or others and any
liabilities the Company may be subject to pursuant to law.

 

4.7
Reservation of Common Stock. As of the date hereof, the Company has reserved for each Purchaser and the Company shall continue
to reserve and keep available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for each
Purchaser for the purpose of enabling the Company to issue the Shares pursuant to this Agreement and Warrant Shares issuable upon
complete exercise of the Warrants (such amount being the “Required Minimum”). If, on any date, the number of
authorized but unissued (and otherwise unreserved) shares of Common Stock is less than the Required Minimum on such date (an “Authorized
Share Failure”), then the Board of Directors shall use commercially reasonable efforts to amend the Company’s
certificate of incorporation to increase the number of authorized but unissued shares of Common Stock to at least the Required
Minimum at such time, as soon as possible and in any event not later than the 90th day after such date. Without limiting
the generality of the foregoing sentence, as soon as practicable after the date of the occurrence of an Authorized Share Failure,
but in no event later than ninety (90) days after the occurrence of such Authorized Share Failure, the Company shall hold a meeting
of its stockholders for the approval of an increase in the number of authorized shares of Common Stock. In connection with such
meeting, the Company shall provide each stockholder with a proxy statement and shall use its commercially reasonable efforts to
solicit its stockholders’ approval of such increase in authorized shares of Common Stock and to cause its board of directors
to recommend to the stockholders that they approve such proposal. Notwithstanding the foregoing, if any such time of an Authorized
Share Failure, the Company is able to obtain the written consent of a majority of the shares of its issued and outstanding Common
Stock to approve the increase in the number of authorized shares of Common Stock without soliciting its stockholders, the Company
may satisfy this obligation by obtaining such consent and submitting for filing with the SEC an Information Statement on Schedule
14C.

 

    20

     

    

 

4.8
Reimbursement. If any Purchaser becomes involved in any capacity in any Proceeding by or against any Person who is a stockholder
of the Company (except as a result of sales, pledges, margin sales and similar transactions by such Purchaser to or with any current
stockholder), solely as a result of such Purchaser’s acquisition of the Securities under this Agreement, the Company will
reimburse such Purchaser for its reasonable legal and other expenses (including the cost of any investigation preparation and
travel in connection therewith) incurred in connection therewith, as such expenses are incurred. The reimbursement obligations
of the Company under this paragraph shall be in addition to any liability which the Company may otherwise have, shall extend upon
the same terms and conditions to any Affiliates of the Purchasers who are actually named in such action, proceeding or investigation,
and partners, directors, agents, employees and controlling persons (if any), as the case may be, of the Purchasers and any such
Affiliate, and shall be binding upon and inure to the benefit of any successors, assigns, heirs and personal representatives of
the Company, the Purchasers and any such Affiliate and any such Person. The Company also agrees that neither the Purchasers nor
any such Affiliates, partners, directors, agents, employees or controlling persons shall have any liability to the Company or
any Person asserting claims on behalf of or in right of the Company solely as a result of acquiring the Securities under this
Agreement.

 

4.9
Form D; Blue Sky Filings. The Company agrees to timely file a Form D with respect to the sale of the Securities by the
Company under this Agreement as required under Regulation D. The Company shall take such action as the Company shall reasonably
determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at the Closing
under applicable securities or “Blue Sky” laws of the states of the United States, and shall provide evidence of such
actions promptly upon request of any Purchaser.

 

4.10
Exercise Procedure. The form of Notice of Exercise included in the Warrants sets forth the totality of the procedures required
of the Purchasers in order to exercise the Warrants. No additional legal opinion, other information or instructions shall be required
of the Purchasers to exercise their Warrants. The Company shall honor exercises of the Warrants and shall deliver Warrant Shares
in accordance with the terms, conditions and time periods set forth in the Transaction Documents.

 

4.11
Most Favored Nations. For the period beginning on the final Closing Date and ending on the date that is twenty-four (24)
months therefrom, other than in connection with an Exempt Issuance, if at any time the Company shall issue any Common Stock or
securities convertible into or exercisable for shares of Common Stock (or modify any of the foregoing which may be outstanding)
to any person or entity at a price per share or conversion or exercise price per share which shall be less than the Unit Purchase
Price in effect at such time, without consent of a Majority in Interest (the “Lower Price Issuance”) and other
than with regard to Excepted Issuances, then the Company shall issue the Purchaser such number of additional Units to reflect
such lower price for the Units such that the Purchaser shall hold such number of Units, in total, had Purchaser paid a Unit Purchase
Price equal to the Lower Price Issuance (with any fractional shares rounded down to the nearest whole number). Common Stock issued
or issuable by the Company for no consideration or for consideration that cannot be determined at the time of issue will be deemed
issuable or to have been issued for $0.0001 per share of Common Stock. For the avoidance of doubt, no adjustment will be made
to the exercise price of the Warrants contained in the Units as a result of a Lower Price Issuance.

 

    21

     

    

 

ARTICLE
V.

MISCELLANEOUS

 

5.1
Termination. This Agreement may be terminated by any Purchaser, as to such Purchaser’s obligations hereunder only
and without any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice given at
any time to the Company, prior to the occurrence of a Closing with respect to such Purchaser’s Subscription Agreement. In
the event of any termination by a Purchaser under this Section 5.1, the Company shall promptly (and in any event within two (2)
Business Days of such termination) refund all of such Purchaser’s subscription amount. No Closing hereunder may take place
after November 30, 2018, subject to a thirty (30) day extension upon the sole discretion of the Board of Directors.

 

5.2
Fees and Expenses. Except as expressly set forth in the Transaction Documents, each party shall pay the fees and expenses
of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the
negotiation, preparation, execution, delivery and performance of this Agreement. Except as set forth in the Warrants, the Company
shall pay all Transfer Agent fees, stamp taxes and other similar taxes and duties levied in connection with the delivery of any
Securities to the Purchasers.

 

5.3
Entire Agreement. The Transaction Documents, together with the exhibits and schedules thereto, and including the Disclosure
Schedule, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede
all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been
merged into such documents, exhibits and schedules.

 

5.4
Notices. All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder
shall be in writing and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered
or certified, return receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid,
or (iv) transmitted by hand delivery, telegram, or facsimile, addressed as set forth below or to such other address as such party
shall have specified most recently by written notice. Any notice or other communication required or permitted to be given hereunder
shall be deemed effective (a) upon hand delivery or delivery by facsimile, with accurate confirmation generated by the transmitting
facsimile machine, at the address or number designated below (if delivered on a business day during normal business hours where
such notice is to be received), or the first business day following such delivery (if delivered other than on a business day during
normal business hours where such notice is to be received) or (b) on the second business day following the date of mailing by
express courier service, prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur.
The addresses for such communications shall be: (i) if to the Company, to: 3301 SE 14th Avenue, Fort Lauderdale, FL
33316, and (ii) if to the Purchasers, to: the addresses and fax numbers indicated on the signature pages hereto.

 

5.5
Amendments; Waivers. No provision of this Agreement may be waived, modified, supplemented or amended except in a written
instrument signed, in the case of an amendment, by the Company and the Purchasers holding at least a majority of the Shares sold
in the Offering then outstanding (such majority being the “Majority in Interest”) or, in the case of a waiver, by
the party against whom enforcement of any such waived provision is sought. No waiver of any default with respect to any provision,
condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent
default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise
any right hereunder in any manner impair the exercise of any such right. As employed herein, “consent” shall mean
consent of the Majority in Interest on the date such consent is requested or required.

 

    22

     

    

 

5.6
Headings. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed
to limit or affect any of the provisions hereof.

 

5.7
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors
and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written
consent of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any
Person to whom such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound,
with respect to the transferred Securities, by the provisions of the Transaction Documents that apply to the “Purchasers.” 

 

5.8
No Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors
and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as
otherwise set forth in Section 4.7.

 

5.9
Governing Law. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard
to the principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement
and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a
party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be
commenced exclusively in the state and federal courts sitting in the City of New York. Each party hereto and each individual signing
any Transaction Document on behalf of the Company hereby irrevocably submits to the exclusive jurisdiction of the state and federal
courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith
or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction
Documents), and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it, he or
she is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an
inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process
being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery
(with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such
service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to
limit in any way any right to serve process in any other manner permitted by law. If either party shall commence an action or
proceeding to enforce any provisions of the Transaction Documents, then in addition to the obligations of the Company under Section
4.7, the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for its reasonable attorneys’
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.

 

5.10
Survival. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities
at the Closings for the applicable statute of limitations.

 

5.11
Execution. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other
party, it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by
facsimile transmission or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and
binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if
such facsimile or “.pdf” signature page were an original thereof.

 

    23

     

    

 

5.12
Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction
to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein
shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use
their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result
as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention
of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any
of such that may be hereafter declared invalid, illegal, void or unenforceable.

 

5.13
Rescission and Withdrawal Right. Notwithstanding anything to the contrary contained in (and without limiting any similar
provisions of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under
a Transaction Document and the Company does not timely perform its related obligations within the periods therein provided, then
such Purchaser may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant
notice, demand or election in whole or in part without prejudice to its future actions and rights; provided, however, that in
the case of a rescission of an exercise of a Warrant, the applicable Purchaser shall be required to return any Warrant Shares
subject to any such rescinded exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid
to the Company for such Warrant Shares and the restoration of such Purchaser’s right to acquire such Warrant Shares pursuant
to such Purchaser’s Warrant (including, issuance of a replacement warrant certificate evidencing such restored right).

 

5.14
Replacement of Securities. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for and upon surrender and cancellation thereof (in
the case of mutilation), or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence
reasonably satisfactory to the Company of such loss, theft, destruction, or mutilation, and of the ownership of such Security.
The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs (including
customary indemnity and bonds) associated with the issuance of such replacement Securities.

 

5.15
Remedies. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of
damages, each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The
parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations
contained in the Transaction Documents and hereby agree to waive and not to assert in any action for specific performance of any
such obligation the defense that a remedy at law would be adequate.

 

5.16
Payment Set Aside. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction
Document or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement
or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered
from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other
Person under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of
action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be
revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.

 

    24

     

    

 

5.17
Legal Representation. Each Purchaser acknowledges that it has been represented by independent legal counsel in the preparation
of the Agreement. Each Purchaser recognizes and acknowledges that counsel to the Company has represented other shareholders of
the Company, including certain of the Purchasers, and may, in the future, represent others in connection with various legal matters
and each Purchaser waives any conflicts of interest and other allegations that it has not been represented by its own counsel.

 

5.18
Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next
succeeding Business Day.

 

5.19
Construction. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity
to revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to
be resolved against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments
thereto. In addition, each and every reference to share prices and shares of Common Stock in any Transaction Document shall be
subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions
of the Common Stock that occur after the date of this Agreement.

 

5.20
Usury. To the extent it may lawfully do so, the Company hereby agrees not to insist upon or plead or in any manner whatsoever
claim, and will resist any and all efforts to be compelled to take the benefit or advantage of, usury laws wherever enacted, now
or at any time hereafter in force, in connection with any claim, action or proceeding that may be brought by any Purchaser in
order to enforce any right or remedy under any Transaction Document. Notwithstanding any provision to the contrary contained in
any Transaction Document, it is expressly agreed and provided that the total liability of the Company under the Transaction Documents
for payments in the nature of interest shall not exceed the maximum lawful rate authorized under applicable law (the “Maximum
Rate”), and, without limiting the foregoing, in no event shall any rate of interest or default interest, or both of
them, when aggregated with any other sums in the nature of interest that the Company may be obligated to pay under the Transaction
Documents exceed such Maximum Rate. It is agreed that if the maximum contract rate of interest allowed by law and applicable to
the Transaction Documents is increased or decreased by statute or any official governmental action subsequent to the date hereof,
the new maximum contract rate of interest allowed by law will be the Maximum Rate applicable to the Transaction Documents from
the Closing Date thereof forward, unless such application is precluded by applicable law. If under any circumstances whatsoever,
interest in excess of the Maximum Rate is paid by the Company to any Purchaser with respect to indebtedness evidenced by the Transaction
Documents, such excess shall be applied by such Purchaser to the unpaid principal balance of any such indebtedness or be refunded
to the Company, the manner of handling such excess to be at such Purchaser’s election.

 

5.21
WAIVER OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY,
THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,
IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.

 

5.22
Equitable Adjustment. Trading volume amounts, price/volume amounts and similar figures in the Transaction Documents shall
be equitably adjusted (but without duplication) to offset the effect of stock splits, similar events and as otherwise described
in this Agreement and Warrants. 

 

(Signature
Pages Follow)

 

    25

     

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.

 

	FMC GLOBALSAT HOLDINGS, INC.	 	Address for Notice:
	 	 	 
	By: 	                  	 	 
	Name:	 	 	 
	Title: 	 	 	 
	 	 	 
	With a copy to (which shall not
    constitute notice):	 	 
	 	 	 
	Company Counsel	 	 

  

[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK

SIGNATURE
PAGE FOR PURCHASER FOLLOWS]

 

     

     

    

 

[PURCHASER
SIGNATURE PAGES TO FMC GLOBALSAT HOLDINGS, INC.

SECURITIES
PURCHASE AGREEMENT]

 

IN
WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.

 

Name
of Purchaser: ________________________________________________________________

  

Signature
of Authorized Signatory of Purchaser: __________________________________________

  

Name
of Authorized Signatory: _______________________________________________________

  

Title
of Authorized Signatory: ________________________________________________________

 

Address
for Delivery of Securities to Purchaser (if not same as address for notice):

 

______________________________________________________________________________

 

______________________________________________________________________________

 

______________________________________________________________________________

  

Subscription
Amount: US$________________

 

Shares
of Common Stock at $1.00 per Unit: ___________________

 

Warrants
___________________

 

EIN
Number, if applicable, will be provided under separate cover.

  

     

     

    

 

EXHIBITS

 

	Exhibit
    A	Form
    of Warrant
	Exhibit
    B	Escrow
    Agreement
	Exhibit
    C	Form
    of Investor Questionnaire

  

     

     

    

 

EXHIBIT
C

 

ACCREDITED
INVESTOR QUESTIONNAIRE

IN
CONNECTION WITH INVESTMENT IN UNITS OF FMC GLOBALSAT HOLDINGS, INC.,

A
DELAWARE CORPORATION

PURSUANT
TO SECURITIES PURCHASE AGREEMENT DATED             , 2018

 

	To :	FMC
    GlobalSat Holdings, Inc.
	 	3301
    SE 14thA venue
	 	Fort
    Lauderdale, FL 33316
	 	Fax:
    [                      ]

 

INSTRUCTIONS

 

PLEASE
ANSWER ALL QUESTIONS. If the appropriate answer is “None” or “Not Applicable”, so state. Please print
or type your answers to all questions. Attach additional sheets if necessary to complete your answers to any item.

 

Your
answers will be kept strictly confidential at all times. However, FMC GlobalSat Holdings, Inc. (collectively, the “Company”)
may present this Questionnaire to such parties as it deems appropriate in order to assure itself that the offer and sale of securities
of the Company will not result in a violation of the registration provisions of the Securities Act of 1933, as amended, or a violation
of the securities laws of any state.

 

1.
Please provide the following information:

 

Name:_________________________________________________________________________

 

Name
of additional purchaser:_______________________________________________________

(Please complete information in Question 5)

 

Date
of birth, or if other than an individual, year of organization or incorporation:

 

2.
Residence address, or if other than an individual, principal office address:

 

______________________________________________________________________________

 

_____________________________________________________________________________

 

______________________________________________________________________________

 

Telephone
number:_______________________________________________________________

 

Social
Security Number:___________________________________________________________

 

Taxpayer
Identification Number:_____________________________________________________

 

     

     

    

 

3.
Business address:______________________________________________________________

 

______________________________________________________________________________

 

______________________________________________________________________________

 

Business
telephone number:_________________________________________________________

 

4.
Send mail to:                                               Residence ______                                        Business _______

 

5.
With respect to tenants in common, joint tenants and tenants by the entirety, complete only if information differs from that above:

 

Residence
address:________________________________________________________________

 

______________________________________________________________________________

 

______________________________________________________________________________

 

Telephone
number:_______________________________________________________________

 

Social
Security Number:___________________________________________________________

 

Taxpayer
Identification Number:_____________________________________________________

 

Business
address:_________________________________________________________________

 

______________________________________________________________________________

 

______________________________________________________________________________

 

Business
telephone number:_________________________________________________________

 

Send
Mail to:                                               Residence ______                                        Business _______

 

6.
Please describe your present or most recent business or occupation and indicate such information as the nature of your employment,
how long you have been employed there, the principal business of your employer, the principal activities under your management
or supervision and the scope (e.g. dollar volume, industry rank, etc.) of such activities:

 

______________________________________________________________________________

 

______________________________________________________________________________

 

______________________________________________________________________________

 

7.
Please state whether you (i) are associated with or affiliated with a member of the Financial Industry Regulatory Association,
Inc. (“FINRA”), (ii) are an owner of stock or other securities of FINRA member (other than stock or other securities
purchased on the open market), or (iii) have made a subordinated loan to any FINRA member:

 

	 	_______	 	_______	 
	 	Yes	 	No	 

 

     

     

    

 

If
you answered yes to any of (i) – (iii) above, please indicate the applicable answer and briefly describe the facts below:

 

______________________________________________________________________________

 

______________________________________________________________________________

 

______________________________________________________________________________

 

8A.Applicable
to Individuals ONLY. Please answer the following questions concerning your financial condition as an “accredited investor”
(within the meaning of Rule 501 of Regulation D). If the purchaser is more than one individual, each individual must initial an
answer where the question indicates a “yes” or “no” response and must answer any other question fully,
indicating to which individual such answer applies. If the purchaser is purchasing jointly with his or her spouse, one answer
may be indicated for the couple as a whole:

 

8.1
Does your net worth* (or joint net worth with your spouse) exceed $1,000,000?

 

	 	_______	 	_______	 
	 	Yes	 	No	 

 

8.2
Did you have an individual income** in excess of $200,000 or joint income together with your spouse in excess of $300,000 in each
of the two most recent years and do you reasonably expect to reach the same income level in the current year?

 

	 	_______	 	_______	 
	 	Yes	 	No	 

 

8.3
Are you an executive officer of the Company?

 

	 	_______	 	_______	 
	 	Yes	 	No	 

 

*
For purposes hereof, net worth shall be deemed to include ALL of your assets, liquid or illiquid MINUS any liabilities.

 

**
For purposes hereof, the term “income” is not limited to “adjusted gross income” as that term is defined
for federal income tax purposes, but rather includes certain items of income which are deducted in computing “adjusted gross
income”. For investors who are salaried employees, the gross salary of such investor, minus any significant expenses personally
incurred by such investor in connection with earning the salary, plus any income from any other source including unearned income,
is a fair measure of “income” for purposes hereof. For investors who are self-employed, “income” is generally
construed to mean total revenues received during the calendar year minus significant expenses incurred in connection with earning
such revenues.

 

     

     

    

 

8.B
Applicable to Corporations, Partnerships, Trusts, Limited Liability Companies and other Entities ONLY:

 

The
purchaser is an accredited investor because the purchaser falls within at least one of the following categories (Check all appropriate
lines):

 

	 	___	(i) a bank as defined
    in Section 3(a)(2) of the Act or a savings and loan association or other institution as defined in Section 3(a)(5)(A) of the
    Act whether acting in its individual or fiduciary capacity;

 

	 	___	(ii) a broker-dealer
    registered pursuant to Section 15 of the Securities Exchange Act of 1934, as amended;

 

	 	___	(iii) an insurance
    company as defined in Section 2(13) of the Act;

 

	 	___	(iv) an investment
    company registered under the Investment Company Act of 1940, as amended (the “Investment Act”) or a business development
    company as defined in Section 2(a)(48) of the Investment Act;

 

	 	___	(v) a Small Business
    Investment Company licensed by the U.S. Small Business Administration under Section 301(c) or (d) of the Small Business Investment
    Act of 1958, as amended;

 

	 	___	(vi) a plan established
    and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions,
    for the benefit of its employees, where such plan has total assets in excess of $5,000,000;

 

	 	___	(vii) an employee
    benefit plan within the meaning of Title 1 of the Employee Retirement Income Security Act of 1974, as amended (the “Employee
    Act”), where the investment decision is made by a plan fiduciary, as defined in Section 3(21) of the Employee Act, which
    is either a bank, savings and loan association, insurance company, or registered investment adviser, or an employee benefit
    plan that has total assets in excess of $5,000,000, or a self-directed plan the investment decisions of which are made solely
    by persons that are accredited investors;

 

	 	___	(viii) a private
    business development company, as defined in Section 202(a)(22) of the Investment Advisers Act of 1940, as amended;
	 	 	 
	 	___	(ix)
    an organization described in Section 501(c)(3) of the Internal Revenue Code, a corporation, a Massachusetts or similar business
    trust, or a partnership, not formed for the specific purpose of acquiring the securities offered, with total assets in excess
    of $5,000,000;

 

	 	___	(x) a trust, with
    total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the securities offered, whose purchase
    is directed by a “sophisticated” person, as described in Rule 506(b)(2)(ii) promulgated under the Act, who has
    such knowledge and experience in financial and business matters that he or she is capable of evaluating the merits and risks
    of the prospective investment;

 

	 	___	(xi) an entity in
    which all of the equity investors are persons or entities described above (“accredited investors”). ALL EQUITY
    OWNERS MUST COMPLETE “EXHIBIT A” ATTACHED HERETO.

 

     

     

    

 

9.A
Do you have sufficient knowledge and experience in financial and business matters so as to be capable of evaluating the merits
and risks associated with investing in the Company?

 

	 	_______	 	_______	 
	 	Yes	 	No	 

 

ANSWER
QUESTION 9B ONLY IF THE ANSWER TO QUESTION 9A WAS “NO.”

 

9.B
If the answer to Question 9A was “NO,” do you have a financial or investment adviser (a) that is acting in the capacity
as a purchaser representative and (b) who has sufficient knowledge and experience in financial and business matters so as to be
capable of evaluating the merits and risks associated with investing in the Company?

 

	 	_______	 	_______	 
	 	Yes	 	No	 

 

If
you have a financial or investment adviser(s), please identify each such person and indicate his or her business address and telephone
number in the space below. (Each such person must complete, and you must review and acknowledge, a separate Purchaser Representative
Questionnaire which will be supplied at your request).

 

______________________________________________________________________________

 

______________________________________________________________________________

 

10.
You have the right, will be afforded an opportunity, and are encouraged to investigate the Company and review relevant factors
and documents pertaining to the officers of the Company, and the Company and its business and to ask questions of a qualified
representative of the Company regarding this investment and the properties, operations, and methods of doing business of the Company.

 

Have
you or has your purchaser representative, if any, conducted any such investigation, sought such documents or asked questions of
a qualified representative of the Company regarding this investment and the properties, operations, and methods of doing business
of the Company?

 

	 	_______	 	_______	 
	 	Yes	 	No	 

 

If
so, briefly describe:_____________________________________________________________

 

______________________________________________________________________________

 

If
so, have you completed your investigation and/or received satisfactory answers to your questions?

 

	 	_______	 	_______	 
	 	Yes	 	No	 

 

11.
Do you understand the nature of an investment in the Company and the risks associated with such an investment?

 

	 	_______	 	_______	 
	 	Yes	 	No	 

 

12.
Do you understand that there is no guarantee of any financial return on this investment and that you will be exposed to the risk
of losing your entire investment?

 

	 	_______	 	_______	 
	 	Yes	 	No	 

 

     

     

    

 

13.
Do you understand that this investment is not liquid?

 

	 	_______	 	_______	 
	 	Yes	 	No	 

 

14.
Do you have adequate means of providing for your current needs and personal contingencies in view of the fact that this is not
a liquid investment?

 

	 	_______	 	_______	 
	 	Yes	 	No	 

 

15.
Are you aware of the Company’s business affairs and financial condition, and have you acquired all such information about
the Company as you deem necessary and appropriate to enable you to reach an informed and knowledgeable decision to acquire the
Interests?

 

	 	_______	 	_______	 
	 	Yes	 	No	 

 

16.
Do you have a “pre-existing relationship” with the Company or any of the officers of the Company?

 

	 	_______	 	_______	 
	 	Yes	 	No	 

 

(For
purposes hereof, “pre-existing relationship” means any relationship consisting of personal or business contacts of
a nature and duration such as would enable a reasonably prudent investor to be aware of the character, business acumen, and general
business and financial circumstances of the person with whom such relationship exists.)

 

If
so, please name the individual or other person with whom you have a pre-existing relationship and describe the relationship:

______________________________________________________________________________

 

______________________________________________________________________________

 

     

     

    

 

17.
Exceptions to the representations and warranties made in Section 3.2 of the Securities Purchase Agreement (if no exceptions, write
“none” – if left blank, the response will be deemed to be “none”): _______________________________________

 

_____________________________________________________________________________

 

Dated:
_______________, 2018

 

If
purchaser is one or more individuals (all individuals must sign):

 

______________________________________________________________________________

(Type or print name of prospective purchaser)

 

______________________________________________________________________________

Signature of prospective purchaser

 

______________________________________________________________________________

Social Security Number

 

______________________________________________________________________________

(Type or print name of additional purchaser)

 

______________________________________________________________________________

Signature of spouse, joint tenant, tenant in common or other signature, if required

 

______________________________________________________________________________

Social Security Number

 

     

     

    

 

Annex
A

Definition
of Accredited Investor

 

The
securities will only be sold to investors who represent in writing in the Securities Purchase Agreement that they are accredited
investors, as defined in Regulation D, Rule 501 under the Act which definition is set forth below:

 

1.
A natural person whose net worth, or joint net worth with spouse, at the time of purchase exceeds $1 million (excluding home);
or

 

2.
A natural person whose individual gross income exceeded $200,000 or whose joint income with that person’s spouse exceeded
$300,000 in each of the last two years, and who reasonably expects to exceed such income level in the current year; or

 

3.
A trust with total assets in excess of $5 million, not formed for the specific purpose of acquiring the securities offered, whose
purchase is directed by a sophisticated person described in Regulation D; or

 

4.
A director or executive officer of the Company; or

 

5.
The investor is an entity, all of the owners of which are accredited investors; or

 

6.
(a) bank as defined in Section 3(a)(2) of the Act, or any savings and loan association or other institution as defined in Section
3(a)(5)(A) of the Act, (b) any broker or dealer registered pursuant to Section 15 of the Securities Exchange Act of 1934, (c)
an insurance Company as defined in Section 2(13) of the Act, (d) an investment Company registered under the Investment Company
Act of 1940 or a business development Company as defined in Section 2(a)(48) of such Act, (e) a Small Business Investment Company
licensed by the United States Small Business Administration under Section 301(c) or (d) of the Small Business Investment Act of
1958, (f) an employee benefit plan established and maintained by a state, its political subdivisions, or any agency or instrumentality
of a state or its political subdivisions, if such plan has total assets in excess of $5 million, (g) an employee benefit plan
within the meaning of Title I of the Employee Retirement Income Securities Act of 1974, and the employee benefit plan has assets
in excess of $5 million, or the investment decision is made by a plan fiduciary, as defined in Section 3(21) of such act, that
is either a bank, savings and loan institution, insurance Company, or registered investment advisor, or, if a self-directed plan,
with an investment decisions made solely by persons that are accredited investors, (h) a private business development company
as defined in Section 202(a)(22) of the Investment Advisers Act of 1940, or (i) an organization described in Section 501(c)(3)
of the Internal Revenue code, corporation, Massachusetts or similar business trust, or partnership, not formed for the specific
purpose of acquiring the securities offered, with assets in excess of $5 million.

 

     

     

    

 

EXHIBIT
“A” TO ACCREDITED INVESTOR QUESTIONNAIRE

 

ACCREDITED
CORPORATIONS, PARTNERSHIPS, LIMITED LIABILITY COMPANIES, TRUSTS OR OTHER ENTITIES INITIALING QUESTION 8B(xi) MUST PROVIDE THE
FOLLOWING INFORMATION.

 

I hereby certify that set forth below is
a complete list of all equity owners in __________________ [NAME OF ENTITY], a                                               
[TYPE OF ENTITY] formed pursuant to the laws of the State of                                    
. I also certify that EACH SUCH OWNER HAS INITIALED THE SPACE OPPOSITE HIS OR HER NAME and that each such owner understands
that by initialing that space he or she is representing that he or she is an accredited individual investor satisfying the test
for accredited individual investors indicated under “Type of Accredited Investor.”

 

	 	___________________________________________________
	 	signature
    of authorized corporate officer, general partner or trustee
	 	 
	                Name
    of Equity Owner	Type
    of Accredited Investor1

 

1.____________________________________________________________________________

 

2.____________________________________________________________________________

 

3.____________________________________________________________________________

 

4.____________________________________________________________________________

 

5.____________________________________________________________________________

 

6.____________________________________________________________________________

 

7.____________________________________________________________________________

 

8.____________________________________________________________________________

 

9.____________________________________________________________________________

 

10.___________________________________________________________________________

 

 

 

1 
     Indicate which Subparagraph of 8.1 - 8.3 the equity owner satisfies.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00299-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00299-of-00352.parquet"}]]